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Abstract
Protein disulfide isomerase (PDI), the chief endoplasmic reticulum (ER)-resident
oxidoreductase chaperone, is known to catalyze the maturation of disulfide-bond-containing
proteins primarily through oxidation-reduction and isomerization functions. The ratedetermining step in the oxidative regeneration path of disulfide-bond-containing proteins
generally couples chemical thiol-disulfide-exchange reactions to a physical conformational
folding reaction. I have determined the impact of PDI and its subdomains on the ratedetermining step in ribonuclease A folding and on the physical structure-forming step of select
ER-processed proteins including RNase A. This was facilitated through application of a novel
chemical tool to exclusively populate native-disulfide-containing intermediates in unstructured
forms. The described biochemical inroad permits a deconvoluted study of the physical halfprocess in the rate-determining step from its chemical counterpart. Analysis of folding kinetics of
RNase A and other proteins reveal that the highly evolved oxidoreductase activity of PDI masks
its chaperone-like activity, impedes conformational folding of ER-processed proteins, and limits
its potential to accelerate the rate-determining step in oxidative regeneration. Implications of the
heretofore unknown and anomalous self-limiting behavior of PDI are discussed in the context of
oxidative maturation and misfolding in vivo.
Nitrosative stress has recently been demonstrated as a causal in a select sporadic variant of
Parkinson’s (PD) and Alzheimer’s (AD) diseases. Specifically, elevated levels of Nitric Oxide
(NO) disrupt the redox activity of protein disulfide isomerase by S-nitroso modification of its
redox-active cysteines. This leads to accumulation of misfolded AD- and PD-specific proteins. I
have recently demonstrated in vitro that polyphenolic phytochemicals, curcumin and
masoprocol, can prevent S-nitroso-PDI formation by scavenging NO*. In this study, using
v

dopaminergic SHSY-5Y cells, I have monitored the aggregation of green-fluorescent protein
(GFP)-tagged synphilin-1 (a known constituent of PD Lewy neurites) as a function of rotenoneinduced nitrosative stress.

Importantly, I demonstrate a marked decrease in synphilin-1

aggregation when the cell line is previously incubated with 3, 5-bis (2-flurobenzylidene)
piperidin-4-one (EF24), a curcumin analogue, prior to rotenone insult. Furthermore, my data also
reveal that rotenone attenuates PDI expression in the same cell line, a phenomenon that can be
mitigated through EF24 intervention. I was also interested to investigate the bioavailability of EF
24 through binding assay with a specific carrier protein, human serum albumin (HSA). With high
affinity binding sites, HSA is a major transporter for delivering several endogenous compounds
and drugs in vivo. In this dissertation, the binding parameters of EF 24 to HSA have been
determined.
Together, these results suggest that polyphenolic phytochemical EF24 can exert
neuroprotective effects by ameliorating nitrosative stress-linked damage to PDI and the
associated onset of PD in tested models. Essentially, EF24 can serve as a scaffold for the design
and development of PD and AD specific prophylactics.
Another aspect of this dissertation was to investigate the role of PDI in cancer. PDI can bind
to estrogens as well as interact with its receptor protein (i.e., estrogen receptors (Er) α and β,
respectively). It has previously been shown that PDI also acts as an intracellular 17β-estradiol
(E2)-binding protein that transports and accumulates E2 in live cells. Intracellular PDI-bound E2
can be released from PDI upon a drop in E2 levels; the released E2 can augment estrogen
receptor-mediated transcriptional activity and mitogenic action in cultured cells by modulating
the Erβ/Erα ratio. In this dissertation, I observed a significant increase in Erβ/Erα ratio, upon
rotenone-induced insult to PDI. Specifically, rotenone-induced insult to PDI leads to the downvi

regulation of ERα and up-regulation of ERβ proteins, respectively. My data also shoId that the
PDI-dependent disruption of the estrogenic status of cells can be restored through intervention by
the polyphenolic curcumin analog, diphenyl difluoroketone (EF24), which acts by rescuing PDI
from reactive oxygen species-induced damage. My study indicates that EF24 can play a vital role
in maintaining estrogenic status in target cells suggesting future applications in select cancers.
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Chapter 1:
Introduction

1.1 Mechanism of protein synthesis and protein folding
Proteins are macromolecules composed of amino acids and are responsible for carrying out
many cellular functions within an organism (1). Proteins are gene products encoded by DNA (1).
Each protein has a specific structure that is determined mostly by its primary amino acid
sequence (1). Some biological processes that proteins are involved in include signaling and
trafficking of substrates, catalysis of biochemical reactions, defense against pathogens and
folding of other proteins (1). Protein synthesis involves the transcription of a DNA template into
messenger RNA folloId by the translation of mRNA to a primary amino acid sequence.
Translation is the last step of gene expression but can be considered the first step in the
formation of a fully functional protein (scheme 1.1). Synthesis of peptide chains determined by
mRNA occurs on ribosome located outside of the endoplasmic reticulum (ER) (1).
There are four levels of organization of a protein through which the eventual structure and
function are acquired. The primary structure of a protein is the linear sequence of amino acids
(1). In 1953, Frederick Sanger determined the first full-length amino acid sequence of insulin.
The secondary structure of a protein is regular arrangements of amino acids within localized
regions of the polypeptide chain (2). α-helices and β-sheets stabilized by hydrogen bonds are
examples of a protein’s secondary structure (2). The tertiary structure of a soluble protein is
acquired through the interactions between side-chain amino acids that lie in different regions of
one single peptide chain (2). In general hydrophobic amino acids reside within the interior of the
protein whereas hydrophilic amino acids tend to be solvent-exposed (1).
1

DNA is transcribed to RNA and RNA is translated to an amino acid sequence

Primary amino acid sequences fold to secondary, tertiary, and quaternary structures (β-sheets and α- helices
shown)

SMyce: National Institute of General
Medical Sciences (NIGMS)

Post translational modification and formation of a functional protein

Scheme 1.1. Summary of protein synthesis: transcription, translation, and folding
Often, contributing to tertiary structure is the formation of disulfide bonds between thiolcontaining amino acid residues. Disulfide-bond is a covalent bond that is formed by the coupling
of two thiols (-SH) (1). In chemistry, it is recognized by S-S bond. The chemistry of disulfide
2

bond is very well-known. The formation of disulfide bond from two thiols is a two electron
reaction, which involves an oxidant or electro acceptor (2). In vitro, disulfide bond can be
formed by loss of electrons from two cysteine thiols coupled with the gain of electrons by an
available acceptor, such as molecular oxygen (2).
Finally, the fourth level of protein organization is the quaternary structure in which two or
more peptide chains may assemble together as subunits to form one functional entity (1). Scheme
1.1 summarizes the different steps in protein synthesis and the formation of a functional protein.

Nobel Prize recipient Christian B. Anfinsen, known for the “Anfinsen Dogma”, demonstrated
that denatured proteins can spontaneously fold back to their native three-dimensional
conformation and regain activity. This indicates that the native structure of the protein is
determined by the information given in the primary amino acid sequence (3). Under
physiological conditions the primary amino acid sequence will give rise to the most
thermodynamically stable conformation (4). It has been determined that chaperones facilitate the
protein in its acquisition of native structure. During and after synthesis, proteins may undergo
modifications before becoming fully-functional. Secreted, plasma membrane and lysosomal
proteins contain a signal sequence that will translocate them into the ER lumen for posttranslational modification such as disulfide-bond formation. Disulfide bond formation occurs
when thiol groups from a cysteine are oxidized and forms a covalent bond with thiol group of
another thiol-containing moiety.
The ER retains an oxidizing environment wherein disulfide-bond formation occurs (5). Aside
from disulfide bond formation, other functions of the ER include further fold maturation, multisubunit formation, initiation of glycosylation, and addition of glycolipid anchors (5). ER proteins
3

such as Protein Disulfide Isomerase (PDI) catalyze the assembly and formation of secreted
proteins (5). When the correct three-dimensional structure is acquired, the protein is ready for
transport to its intended location. Secretory proteins are transported from the ER to the Golgi and
finally secreted out of the cell (6). Proteins that are to reside in the ER, such as PDI, are retained
via a KDEL signal sequence (7).

Scheme 1.2. Organization of the cell. Secretory proteins are synthesized in ribosome,
translocated into the ER lumen, oxidized and transported to the Golgi, then to their final
destination and misfolded proteins go to degradation process (Sitia and Braakman, 2003).

Scheme 1.2 represents a simplified organization of the cell and pathway that secreted
proteins undertake prior to reaching their destination. Correct disulfide bond formation is
significant to the structure and function of a protein (6). When unfolded proteins cannot acquire
their conformation, they will form aggregates with exposed hydrophobic regions of other
unfolded proteins (6). Without proper disulfide bond formation, the peptide is degraded or may
form aggregates that will disrupt the overall function of the cell (6).
4

Endoplasmic Reticulum Associated Degradation (ERAD), a process where misfolded
proteins are labeled and sent to proteosomes for degradation, helps reduced accumulation of
protein aggregates within ER (8). Many diseases such as Alzheimer’s and Parkinson’s involve
the formation of large insoluble aggregates. Enzymes and chaperones located in the ER can
facilitate the correct folding of proteins, thereby reducing the formation of aggregates. If
accumulation of misfolded proteins occurs, the cell will experience stress and may become
apoptotic (9).

1.2 Protein disulfide isomerase (PDI)
Protein Disulfide Isomerase (Molecular weight of approximately 57 kDa) is an
oxidoreductase enzyme found in the ER lumen of eukaryotic cells (10). PDI has the ability to
oxidize, reduce, and isomerize disulfide bonds. Disulfide bonding is highly error prone and PDI
has the ability to reshuffle disulfides until acquisition of substrates’ native structure that prevents
access to PDI (11). The abundance of PDI in the cell indicates the importance of its role in fold
maturation of newly synthesized proteins that are destined to transit via the secretory pathway.
Such disulfide-bond-containing proteins constitute 1/3 of the known proteome (5). PDI is part of
the thioredoxin super family (11) and the PDI family of proteins (5). PDI also demonstrates
limited chaperone function through hydrophobic interactions with unfolded proteins (12). PDIrelated studies are important to the understanding of its function and medical advances in
neurodegenerative disorders (11).
PDI is a multi-domain thioredoxin-like (TRX) protein with its active site composed of two –
CGHC- sequences (scheme 1.3). Numbers and positions of the TRX-like catalytic domains vary
among members within the family and it is believed that these variations result from duplication
5

and deletions of an ancestral enzyme over time (13). The two “a” type domains in PDI contain
the oxidoreductase catalytic motif whereas the “b” type domains are implicated in its chaperonelike activity (13).

Scheme 1.3. Schematic diagram of Protein disulfide isomerase (PDI)

1.3 Structure of PDI
The full amino acid sequence of PDI was first determined by Edman and co-workers in 1985.
The complimentary DNA from rat liver was analyzed by amino terminal sequence analysis using
microsequentator (13). The cloned sequence encoded a 508 amino acid protein with a molecular
weight of about 57 kDa and correlated well with the in vitro translated protein (13). It was
presumed that PDI contained two regions homologous to E. coli thioredoxin protein. A sequence
of 19 hydrophobic amino acids at the N terminal was characteristic of a signal sequence
extension possibly localizing the protein in the ER (13).
The two active site-containing regions denoted a and a’ showed 40% homology to each other
(13). The b and b’ are 28% homologous to each other but have no homology to thioredoxin or
other proteins (13). The final domain, c contains a high density of negatively charged amino
acids (13, 14, 15, 16).
There are several PDI paralogs in humans (7) and to a lesser extent also in yeast (15), but
their detailed roles and specificities have not been described. Furthermore, though the exact
boundaries for the domains differ from species to species, there are significant similarity between
6

PDI domains. Individual domains of human PDI as well as constructs of combinations of
domains have been characterized by NMR (17, 18).

Figure 1.1. Overall Structure of PDI, (A) Ribbon diagram of PDI with the a, b, b´, and a´
domains in magenta, cyan, yellow, and red arrows, respectively, and the C-terminal extension in
green arrow. The two orientations roughly differ by a 90º rotation around the horizontal axis. The
side chains of the active site cysteines in the a and a´ domains are shown in spacefilling
representation with the sulfur atoms in yellow. (B) Secondary structure diagram of the canonical
thioredoxin fold with α-helices in green and β strands in red. The location of the active site is
indicated by a red oval (Tian et. al., cell, 2005)

7

Tian et. al., cell, 2005

Figure 1.2 Primary Structure of Mammalian and Yeast PDI.(A) Domain organization of bovine
PDI as deduced from biochemical studies and that of yeast PDI based on the crystal structure (c
represents the C-terminal tail). The C-G-H-C motifs indicate the location of the active sites, the
Cs the nonactive site cysteines, and x the loop connecting the b´ and a´ domains. (B) Multiple
sequence alignment of yeast and mammalian PDIs. Helices and strands are represented by
cylinders and arrows, respectively. Active-site residues in the a and a´ domain are boxed. Black
arrows highlight the two buried polar residues in the vicinity of the active site; white arrows the
nonactive site cysteines; and blue arrows the cis-prolines near each active site. Boxed residues in
8

the b´ domain form a hydrophobic pocket are presumably involved in substrate binding. The
symbol above the sequence represents the secondary structure with arrow standing for β-sheet
and rod standing for α-helix.

1.4 Function of PDI
PDI is one of the highly expressed in mammalian cells because there is a vast number of
proteins that must undergo processing before secretion to their final destinations (5). PDI has
several functions: oxidation and reduction of nascent proteins and isomerization of existing
disulfide bonds. It also possesses chaperone activity and participates in protein degradation.
Because of its structure, PDI can exist in a reduced or oxidized form (5).
Oxidation
Correct folding of proteins is essential for the function of cells and the overall well-being of
organisms. Cytosolic proteins lack disulfide bonds due to the reducing environment of the
cystosol. Proteins destined for secretion must be translocated into the ER and oxidized to obtain
disulfides and become fully functional. The cysteine containing catalytic domains allow PDI to
introduce disulfide bonds to newly-synthesized substrates (19). For disulfide bond formation,
oxidized PDI must transfer its disulfide equivalents to nascent proteins (19). As a result, PDI
becomes reduced. Another ER-resident protein, Ero1 transfers oxidation equivalents to PDI,
thereby recycling the enzyme for oxidation of other substrates (19). The substrate thiol group,
partially deprotonated as a result of ambient pH, attacks PDI disulfide bond and a mixed
disulfide between the substrate and PDI is created (19). Another substrate thiolate can then attack
the mixed disulfide bond resulting in an intramolecular substrate disulfide bond (19). Scheme
3.1A is an illustration of how PDI functions as an oxidation.
9

Isomerization
PDI can also isomerize substrate disulfides by shuffling existing disulfide bonds thereby
allowing the substrate to eventually acquire its native component of diusulfide bond. Early
disulfide bond formation in nascent proteins is error prone. Incorrect disulfide bonds must be
broken and correct disulfide bonds must be made (11). It is PDI’s role to accelerate shuffling so
that the substrate can find its thermodynamically favorable native structure in a timely manner
(11).
Isomerization can be viewed as repeated cycles of reduction and reoxidation of disulfide
bonds via PDI. Cycles will be repeated until a stable structure is formed and the substrate
disulfides are no longer accesible to PDI (11). Both reduction and oxidation reactions are
essential to this pathway (11). The first step in isomerization is breaking an existing
intramolecular substrate disulfide bond by forming a mixed disulfide with (formerly reduced)
PDI. The second step is reoxidation of disulfide bonds between two different cysteine residues.
A brief description follows: the N-terminal cysteine of PDI is deprotonated at physiological pH
due its low pKa (4.5-5) (11). Deprotonation of the cysteine creates a highly reactive thiolate that
attacks an existing disulfide within the substrate. As a result, a mixed disulfide betIen the
substrate and the catalyst will form and several scenarios can follow (11). First, the thiol
participating in the original disulfide bond can attack the mixed disulfide and the substrate will
return to its original state; PDI will be released, and no isomerization occurs (11). Another
scenario is that a third substrate thiolate attacks the mixed disulfide resulting in a disulfide
between two different thiols (isomerization). This mechanism is depicted in scheme 3.1B.
Reduced PDI can attack and reshuffle any exposed disulfide bond and the unfolded substrate is

10

thus subject to continual reshuffling of its disulfides (19). A conformational folding event
resulting in the burial of its (native) disulfides is the only means to escape PDI.

1.5 Free-radical stress
Glutamate is the major excitatory neurotransmitter in the brain and is important for normal
functioning of the nervous system; however, excessive activation of glutamate receptors is
implicated in neuronal damage in many neurological disorders ranging from acute hypoxicischemic brain injury to chronic neurodegenerative diseases. John Olney coined the term
“excitotoxicity” to describe this phenomenon (20). This form of toxicity is mediated at least in
part by excessive activation of N-methyl, D-aspartase-type receptors (NMDA-type receptors),
resulting in excessive Ca2+ influx through a receptor’s associated ion channel (20). Excessive
Ca2+ leads to the production of damaging free radicals [e.g., NO* and reactive oxygen species
(ROS)] and other enzymatic processes, contributing to cell death. Intracellular Ca2+ triggers the
generation of NO* by activating neuronal NO-synthase (nNOS) in a Ca2+calmodulin (CaM)dependent manner (20).
It is currently thought that overstimulation of extrasynaptic NMDA receptors mediates this
neuronal damage; in contrast, synaptic activity may activate survival pathways (20). Intense
hyperstimulation of excitatory receptors leads to necrotic cell death, but more mild or chronic
overstimulation can result in apoptotic or other forms of cell death (20). Increased levels of
neuronal Ca2+, in conjunction with the Ca2+ binding protein CaM, trigger the activation of nNOS
and subsequent generation of NO* from the amino acid L-arginine (20). NO* is a gaseous free
radical (thus highly diffusible) and a key molecule that plays a vital role in normal signal
transduction; However, in excess it can lead to neuronal cell damage and death. Mitochondrial
11

respiratory chain complex 1 inhibitors can produce ROS such as, NO* and *OH. Like NO*,
hydroxyl (*OH) radicals also produces stress in cell and leads to apoptotic cell death (20, 21).

1.6 Free-radical stress mediated chemical modification of PDI
Inhibition of mitochondrial respiratory chain can generate excess production of nitrogen
species (NO*) and in the presence of oxygen, ferrous ions frequently result in oxidative stress
through the generation of hydroxyl radicals via the Fenton reaction (Fe2+ + H2O2→Fe3+ +*OH +
-

OH) (8). The discovery that the free radical reactive oxygen species (ROS) are synthesized and

used as a major transducer molecule by cell promoted dramatic changes in the field of free
radical research; it lead to the current view that free radicals and oxidants play an important role
in cellular homeostasis and stress (11).
This free radical-induced stress can result in posttranslational modification of PDI (22). It has
recently been established that cysteine residues (Cys) in PDI are prominent targets for protein
oxidation, as they easily react with NO* and *OH free radicals (22). Deprotonation of the Cys
thiol group of PDI to generate the thiolate anion increases its nucleophilicity, and hence
reactivity towards free radicals (22). When a thiolate group of PDI is attacked by the NO* and
*OH free radicals, inactive S-nitrosylated-PDI and S-hydroxylated-PDI are formed (22). This
chemical modification of PDI by free radicals destroys PDI’s catalytic activity in oxidative
protein folding.

1.7 Neurodegenerative disease
A shared histological feature of many neurodegenerative diseases is the accumulation of
misfolded proteins that adversely affect neuronal connectivity and plasticity, triggering cell death
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signaling pathways (16). For example, regions of the brain often contain aberrant accumulations
of misfolded, aggregated proteins, such as α-synuclein and synphilin-1 in PD, and amyloid-β
(Aβ) and tau in AD. The inclusions observed in PD are called Lewy bodies and are mostly found
in the cytoplasm of neuronal cells. AD brains show intracellular neurofibrillary tangles, which
contain tau, and extracellular plaques, which contain Aβ. Other diseases with inclusions include
Huntington’s (polyQ), ALS, and prion disease (20). The above-mentioned aggregates consist of
oligomeric complexes of nonnative secondary structures, and demonstrate poor solubility in
aqueous or detergent solvents. It has been suggested that either genetic mutations, or an increase
in nitrosative/ oxidative stress, can facilitate protein aggregation (24). In general, protein
aggregates do not accumulate in unstressed, healthy neurons due in part to the existence of
cellular ‘quality control machineries’. For example, molecular chaperones are believed to
provide a defense mechanism against the toxicity of misfolded proteins because chaperones can
prevent inappropriate interactions within, and between, polypeptides, and can promote refolding
of proteins that have been misfolded because of cellular stress (24).
In addition to the quality control of proteins provided by molecular chaperones, the ubiquitinproteasome system (UPS) is involved in the clearance of abnormal or aberrant proteins (20).
When chaperones cannot repair misfolded proteins, they may be tagged via addition of
polyubiquitin chains for degradation by the proteasome. In neurodegenerative conditions, intraor extracellular protein aggregates are thought to accumulate in the brain as a result of a decrease
in molecular chaperone or proteasome activities. In fact, several mutations that disturb the
activity of molecular chaperones or UPS-associated enzymes can cause neurodegeneration (24).
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1.8 Ubiquitin protease system (UPS)
The UPS represents an important mechanism for proteolysis in mammalian cells (24).
Formation of polyubiquitin chains constitutes the signal for proteasomal attack and degradation.
An isopeptide bond covalently attaches the C-terminus of the first ubiquitin in a polyubiqutin
chain to a lysine residue in the target protein (8). The cascade of activating (E1), conjugating
(E2), and ubiquitin-ligating (E3) type enzymes catalyzes the conjugation of the ubiquitin chain to
proteins (20). In addition, individual E3 ubiquitin ligases play a key role in the recognition of
specific substrates (8).

1.9 Role of free-radical stress-induced modification of PDI in UPS
Chemically, NO* and *OH are often a good “leaving group,” facilitating further oxidation of
critical thiol to disulfide bonds among neighboring (vicinal) cysteine residues or, via reaction
with ROS, to sulfenic (-SOH), sulfinic (-SO2H) or sulfonic (-SO3H) acid derivatization of the
protein (16). Alternatively, S-nitrosylation and S-hydroxylation may possibly produce a nitroxyl
disulfide or hydroxyl disulfide, in which the NO* or *OH group is shared by close cysteine
thiols (20). In addition, free radicals ameliorates the progression of disease pathology in animal
models of PD, AD, and ALS, suggesting that excess generation of NO* and *OH play a pivotal
role in the pathogenesis of several neurodegenerative diseases by disrupting the UPS (8).
Although the involvement of NO* and *OH in neurodegeneration has been widely accepted, the
chemical relationship between nitrosative stress and accumulation of misfolded proteins needs
further investigation. Recent findings, however, have shed light on molecular events underlying
this relationship (24).
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1.10 Free-radical scavengers-polyphenolic phytochemicals
It has been previously demonstrated that polyphenolic phytochemicals, masoprocol (from
Larrea Tridentata) curcumin [a turmeric (Curcuma Longa) spice] protect PDI catalytic function
under conditions of nitrosative and oxidative stress. Curcumin has a wide spectrum of biological
and pharmacological functions including anti-inflammatory, antimicrobial, and anticarcinogenic
(23). It has already been used clinically and is approved by the FDA as a safe food additive (23).
Masoprocol (nordihydroguaiaretic acid (NDGA)) is a potent antioxidant whose derivatives and
analogues are potentially useful in treating diseases related to cancers, diabetes, viral, bacterial
infections, and inflammation (23). Recent efforts to improve its bioavailability (coadministration with other agents and structural modifications) have met with success by
synthesizing curcumin analog, 3, 5-bis (2-flurobenzylidene) piperidin-4-one (EF24) (23).
Bioavailable EF24 can mitigate nitrosative and oxidative stress by scavenging excess NO* and
*OH by forming stable adducts.

1.11 Prophylactic effect of EF24 against free-radical stress mediated misfolded protein
aggregation
Mitochondrial complex-I inhibitors assist production of excess NO* and *OH. Elevated level
of NO* and *OH induces nitrosative and oxidative stress, which is linked to activate certain
caspases and initiates one of the apoptotic pathways in cells (24). Free radical stress has also
been linked to PDI dysfunction and downstream aggregation of misfolding-prone- proteins such
as synphilin-1 and α-synuclein. Formation of Lewy bodies and aggresomes leads to apoptotic
cell death (24). It is hypothesized that scavenging of free radicals by EF24 can prevent covalent
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modification of PDI; EF24 can thereby potentially protect against loss of oxidoreductase
function of PDI and against Lewy neurite deposits, the pathogenesis of PD and AD (23).

1.12 Role of PDI in the estrogenic status of cells
PDI can interact directly with Erα (25) and demonstrates estrogen (Er)-interacting behavior
very similar to Hsp90 and Hsp70 [two well-known chaperone proteins that can alter Er functions
(25)]. PDI, with its possible Erα chaperoning activity, acts as a modulator of estrogen’s hormonal
activity in different target cells. The intracellular PDI-bound estrogens can be released from PDI
to instigate the Er-mediated transcriptional activity as well as mitogenic actions (25). Studies
suggest that PDI plays a critical role in estrogen responsiveness by functioning as a molecular
chaperone and PDI alone is capable of interacting with Erα and influencing its activity (26). I
have observed that PDI can alter Erβ to Erα ratio significantly by altering the levels of two
proteins in opposite directions, down-regulation of Erα and up-regulation of Erβ.

1.13 Role of Nitrosative stress-induced modification of PDI on estrogenic status
It is well-known that nitrosative stress, originating from elevated levels of nitric oxide
(NO*), results in the S-nitrosylation of PDI cysteines (i.e. the covalent modification of PDI
active site cysteines by NO) (23). Initially, I have showed that PDI gets S-nitrosylated (SNO-P)
under nitrosative stress, and NO-induced chemical modification of PDI abolishes its ability to
maintain the normal level of ERβ/ERα ratio by altering the levels of ERβ and ERα. Using
biochemical and molecular techniques, I have studied co-lecolaization of PDI with ERα in
cancer cells (MCF-7) under normal and nitrosative stress condition. Under nitrosative stress, PDI
loses its activity which in turn, may impact estrogenic status.
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1.14 Effect of EF24 in the nitrosative-stress-mediated modification of PDIs’ role in
estrogenic status
Polyphenol, EF24 can scavenge free radicals by forming stable adducts and prevent PDI
from getting S-nitrosylated. PDI can alter Erβ to Erα ratio significantly by altering the levels of
two proteins in opposite directions, down-regulation of Erα and up-regulation of Erβ. PDI plays
an active role in maintaining estrogenic status by controlling the levels of Erβ and Erα. It is of
interest to investigate the role of a ROS-scavenger (EF24) on any alteration of estrogenic status
upon ROS-insult to PDI

1.15 Serum protein human serum albumin (HSA)
Human serum albumin (Scheme 1.4) is the most abundant serum protein, which carries
several endogenous compounds including fatty acids (27). Due to its ability to bind various drug
molecules and alters their pharmacokinetic properties, HSA has long been the center of attention
of pharmaceutical industry (27). HSA is a globular protein composed of three structurally similar
domains (I, II and III), each containing two sub-domains (A and B) and stabilized by 17 disulfide
bridges (28). Aromatic and heterocyclic ligands were found to bind within two hydrophobic
pockets in sub-domains IIA and IIIA, namely site I and site II (28). Seven binding sites for fatty
acids are localized in subdomains IB, IIIA, IIIB and on the subdomain interfaces (28). HSA has
also a high affinity metal binding site at the N-terminus (29). These multiple binding sites
underline the exceptional ability of HSA to interact with many organic and inorganic molecules
and make this protein an important regulator of intercellular fluxes, as Ill as the pharmacokinetic
behavior of many drugs (28).
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Therefore, it was of interest to study the binding of EF24 on protein. The spectroscopic
analysis of HSA complexation with EF24 was carried out in aqueous solution at physiological
conditions, using constant protein concentration to understand the binding affinity of HSA with
EF24.

Scheme 1.4 Diagram of human serum albumin (HSA), PDB: 1E7H

1.16 Dissertation goals
Considering that the ER-resident oxidoreductase and neuroprotectant is involved in protein
misfolding linked to Alzheimer’s in a NO-sensitive manner, PDI is a valuable target for
therapeutic intervention in AD and perhaps other age- and neurodegeneration-related disorders.
Overexpression of PDI may not be a practical solution to neurodegenerative diseases prevention.
Instead, small-molecules that combat the effects of nitrosative stress by scavenging NO*,
rescuing PDI function, and restoring ER homeostasis represent the desired modes of PD and AD
intervention.
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I also hypothesize that under homeostasis, even “healthy” PDI can contribute to debris
accumulation within the cytosol, albeit due to a different reason, will also be tested, making this
study significant from a basic science viewpoint. The aims of this dissertation include
determining mechanisms by which to advance methods to rescue PDI damage and thereby
prevent neurodegenerative diseases and cancer onset; to illuminate a fundamental and heretofore
unknown reason as to how and why protein processing and trafficking within a particular
compartment may have consequences leading to misfolded debris accumulation in a distant site,
eventually contributing to neurodegenerative diseases onset. Eventually I plan to translate my
data to animal models to find therapeutics that target neurodegenerative diseases and cancer.

Specific aim 1:
Rotenone induced nitrosative stress causes apoptotic cell death through caspase activation. Snitrosylation of PDI- cysteines due to nitrosative stress is associated with cytosolic aggresomes
and Lewy bodies. I want to determine if these aggresomes will also lead apoptotic to cell death in
PD and AD brains.
Specific aim 2:
To investigate whether EF24 can act as prophylactic for nitrosative-stress associated AD, PD
and other neurodegeneration-related disorders.
Specific aim 3:
To determine if HSA can bind EF24 and act as a transporter for EF24.
Specific aim 4:
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Rotenone induced nitrosative stress mediated chemical-modification of PDI leads alteration
of estrogen receptor proteins levels. I want to determine the preventive effect of EF24 against
nitrosative stress and ability to maintain homeostasis of the estrogen level.

20

Chapter 2:
The Impact of Oxidoreductase Behavior of Protein Disulfide Isomerase on Protein
Maturation

2.1 Introduction
Oxidative protein folding is characteristic of many proteins that are secreted outside the cell
or, are membrane-bound, and possess disulfide bonds (1-4). It is a composite process because it
involves the chemical formation of the native set of disulfide bonds from the fully-reduced
polypeptide, an event that is coupled to a physical conformational folding reaction to obtain the
native, biologically active structure (1-3). Proteins required to oxidatively fold are processed
(mature) within the endoplasmic reticulum (ER), which facilitates disulfide bond formation
because of a favorable redox potential (4).
A typical oxidative folding reaction comprising the regeneration of bovine pancreatic
ribonuclease A (RNase A) has been done (Fig. 2.1). During its regeneration from the fullyreduced state (R), 28 one-disulfide (1S), 210 two-disulfide (2S), 420 three-disulfide (3S) and 104
scrambled (i.e. nonnative) four-disulfide (4S) containing intermediates are formed (Fig. 2.1) (58). Additionally, two native-like species accumulate in the rate-determining step (RDS) of the
reaction. These are Des [40-95] and Des [65-72] (Des stands for lack) which possess native-like
structure and lack the (40-95) and (65-72) disulfide bond, respectively (9, 10). These structured
intermediates (also referred to as 3S*) are then oxidized to form N (Figure 2.1) (1). The
formation of 3S* from 3S is rate-determining because it involves the formation of two nativedisulfide-bond-containing structured intermediates from an isomer ensemble of 420 unstructured
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intermediates which mostly contain nonnative disulfide bonds, making the search for those two
(3S*) species statistical and hence time-consuming; in RNase A this search is compounded by a
slow conformational folding process. These two processes are elaborated below.

(1)

(28)

(210)

(420)

(104)

R  1S  2S  3S

nonnative

RDS

3Snative { Unstructured des (40‐95)

3S*

 4S

Unstructured des (65‐72)

Des [40-95] Des [65-72]

N
Figure 2.1. Regeneration scheme of RNase A (pH 8, 25 oC). R, 1S, 2S, 3S and 4S are
unstructured intermediates (the numbers above each species refers to the number of existing
isomers when no mixed disulfide containing intermediates are present; such as when using
glutathione as the redox reagent). Des [40-95] and Des [65-72] are native-like three-disulfidebond-containing intermediates and are also referred to as the 3S* species. They are formed from
their unstructured native-disulfide-bond-containing precursors (collectively known as 3Snative)
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by a conformational folding reaction in the rate-determining step (RDS; 3S→3S*). N is the
native protein and is eventually formed by oxidation of native-like 3S* species.

The RDS in most oxidative folding pathways, including that of RNase A, is composed of
chemical and physical half-processes (5-7). The chemical half of the RDS in RNase A involves
thiol-disulfide exchange reactions to populate an unstructured intermediate with native disulfide
bonds

(3Snative)

from

its

nonnative-disulfide-bond-containing

isomers

(3Snonnative)

[(3Snonnative3Snative) (Fig. 2.2). For example, consider the formation of unstructured Des (40-95)
from its 419 unstructured 3S isomers (Panel B). These isomers must chemically reshuffle to
produce an unstructured intermediate (3Snonnative) that is one step away from a chemical
reshuffling reaction to produce unstructured Des (40-95). Such a 3Snonnative species will contain
two native disulfide bonds (solid lines) and one nonnative disulfide bond (dotted line). Similar
scenarios are depicted for unstructured Des (65-72) in Panel C. In both cases, the statistical
dependence of the formation of unstructured Des (40-95) and Des (65-72) from 419 isomers
prolongs the process and contributes to the step becoming rate-determining.
The physical half of the RDS involves a conformational folding event; viz., the nativedisulfide-bond-containing intermediate (3Snative) conformationally folds to generate a native or
native-like structure (3S*) that preserves newly acquired native disulfide bonds by preventing
access to chemical exchange (5-7).
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419 isomers

Physical RXN:
conformat. Fld.

Chemical RXN
Thiol-disulfide
h

3Snative

3Snonnative

A

3S*

B

Chemical RXN:
Thiol-disulfide
h

3Snonnative

Physical RXN:
conformational fldg.

Unstructured des (65-72)

Des [65-72]

C

Chemical RXN:
Thiol-disulfide
h

3Snonnative

Physical RXN:
conformational fldg.

Unstructured des (40-95)
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Des [40-95]

Figure 2.2. Representation of the rate-determining step (RDS) involving the formation of a
structured species from its unstructured precursors via thiol disulfide exchange (chemical
reaction) and confornmational folding (physical reaction) during oxidative folding. Dashed
horizontal lines are nonnative disulfide bonds in an unstructured intermediate, viz. 3Snonnative;
Solid horizontal lines are native disulfide bonds in unstructured (3Snative) and structured
intermediates (3S*). Vertical lines are thiols. A competition exists between reshuffling
(isomerization) reactions [3Snative3Snonnative] and the structure-forming step [3Snative3S*]. A)
Generic pathway of a RDS involving the formation of 3S* via thiol disulfide chemical reactions
and a physical conformational folding reaction from its unstructured isomers.

B) Pathway

showing the formation of des [65-72] from unstructured des (65-72) in RNase A RDS C)
Pathway showing the formation of des [40-95] from unstructured des (40-95) in RNase A RDS.
(RXN in figure stands for reaction).
The physical conformational folding reaction is pivotal to the oxidative folding process
because it removes the newly-structured intermediate from the quasi-equilibrium pool of
unstructured intermediates that are prone to unfruitful oxidation, reduction and reshuffling
reactions (Fig 2.1) (8, 9).
Importantly, the physical conformational folding half of the RDS competes with its chemical
counterpart (thiol-disulfide exchange reactions) (Fig. 2.2) (5-7, 11, 12).

The forward

conformational folding reaction (3Snative3S*) must outcompete back-reshuffling reactions
(3Snative3Snonnative) if a structured (native-like or native) species is to be formed (10, 13).
In RNase A, proline isomerization slows conformational folding of both unstructured des
(40-95) and unstructured des (65-72) to des [40-95] and des [65-72], respectively. Therefore, a
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major fraction of 3Snative species formed in each case reshuffles to its precursor nonnative
disulfide-bond containing isomer (3Snonnative) which can then reshuffle to any of the other 419
nonnative disulfide-bond-containing unstructured isomers (13). Thus, unless a 3Snative species
can fold rapidly, it becomes susceptible to thiol-disulfide exchange. Another search through a
series of time-consuming chemical exchange steps is then required to repopulate 3Snative.
In other protein folding scenarios, the dependence of tertiary structure on a cofactor may
impact conformational folding rates. The competition betIen the “chemical” thiol-disulfide
exchange reaction and the “physical” conformational folding reaction are unique to disulfidebond-containing proteins (7). In vivo, oxidative protein folding is catalyzed by protein disulfide
isomerase (PDI) which possesses oxidase and “shufflase” activity using surface-exposed
cysteines residues (Scheme 1.3) (12, 14-17). Although in vitro studies have demonstrated that
PDI is able to accelerate oxidative folding reactions and catalyze the regeneration of multidisulfide-bond-containing proteins including RNase A (18), the impact of PDI and its domains
on the pivotal structure-coupled step that immediately precedes maturation is yet unknown.
Furthermore, even under surveillance by PDI, a large fraction of ER-processed proteins misfold,
and are trafficked to the proteosome (4).
Given this scenario, and that PDI is the principal machinery charged with oxidative
maturation of ER-processed proteins, it is of interest to examine its catalytic impact on both the
structure-coupled step and the overall rate-determining step in oxidative folding, which is the
subject of this study.
Heretofore, a study of the impact of PDI on the physical half of the RDS has not been
reported; this is now made possible by deconvoluting the chemical half of the RDS from its
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physical half and is essential to obtain a fundamental understanding of the impact of PDI on the
microscopic steps of the RDS. Note that the RDS generally precedes maturation and export from
the ER of disulfide-bond-containing proteins. In this study, I report a tool to exclusively populate
native-disulfide-containing intermediates in unstructured forms that are poised-to-fold or
backreshuffle to “futile” unfolded precursors. The described biochemical inroad permits a
deconvoluted study of the physical half-process in the rate-determining step from its chemical
counterpart and facilitates assessment of PDI’s impact on this step and on ER trafficking in
general. My results reveal that though the chief ER-resident oxidoreductase successfully
catalyzes the overall rate-determining step in RNase A regeneration, it hampers the piviotal
structure-forming step in the maturation of RNase A and other ER-processed proteins.
Furthermore, the chaperone and isomerase catalytic activities of PDI contrast in their ability to
accelerate the formation of the native fold. The implications of these results on trafficking in the
ER, protein misfolding and the onset of neurodegenerative disorders are discussed.

2.2 Materials and Methods
Materials.
RNase A was purchased from Sigma and purified as previously described (8). Protein
disulfide isomerase, null PDI and ab, b’a’ and bb’ constructs were gifts from the laboratory of
Prof. Arne Holmgren (Karolinska Institute, SIden) and were expressed and purified as previously
described (19). Oxidized and reduced dithiothreitol (DTTox and DTTred, respectively) were
purchased from Sigma and used without further purification. All other chemicals were of the
highest grade commercially available.
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Preparation of fully-reduced RNase A.
Fully-reduced RNase A (R) was prepared by incubating native protein (10 mg/ml) in 6 M
Gdn HCl and 100 mM DTTred (pH 8, 100 mM Tris-HCl, 1 mM EDTA) for a period of 2 hours
(8). The mixture was then repeatedly dialyzed against 50 mM acetic acid at 4 oC prior to
lyophilisation. The fully-reduced protein was dissolved into 10 mM acetic acid to obtain a stock
solution (5 mg/ml protein) that was kept frozen (-20oC) until further use.
HPLC isolated Des [40-95] and Des [65-72] were pooled and introduced into 6 M GdnHCl
(pH 8, 100 mM Tris-HCl) as previously described (13). After 5 minutes, the pH of the solution
was quenched by the addition of 20 L glacial acetic acid. The sample was then desalted using a
G-25 column and lyophilized.
Reductive unfolding of native RNase A (5 mg/mL) was initiated by incubation of the protein
in a buffer containing 100 mM DTTred (pH 8, 100 mM Tris-HCl, 1 mM EDTA, 15 oC). 20 hrs
after initiation of reduction, glacial acetic acid was added to reduce the pH to 3. The sample was
desalted using a G-25 column and native-like Des [40-95] and Des [65-72] Ire separated using
strong cation-exchange chromatography as previously described (9).
Des [40-95] and Des [65-72] were pooled and introduced into a pH 2 buffer (containing 50
mM acetic acid) as previously described (13). After 30 minutes of incubation, the solution was
freeze-dried and the lyophilized protein was introduced into a buffer containing 20 mM acetic
acid (pH 3).
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Oxidative folding of RNase A.
Aliquots of fully-reduced RNase A (30 M final conc.) were incubated into solutions (pH 8,
50 mM DTTox, 20 mM Tris-HCl, 1 mM EDTA, 25 oC) containing either 4 M of WT PDI, ab,
bb’ or b’a’ domains. [Note: The use of DTTox, a weak oxidizing agent permits good kinetic
control over regeneration rates and does not lead to the formation of mixed disulfide bonds.
DTTred is not initially added to the regeneration mixture because it is naturally formed upon
oxidation of protein thiols to disulfide bond] A control experiment that did not contain PDI or
any of its domains was run in parallel (8). Aliquots from the regeneration mixture were
withdrawn at several time points after the initiation of oxidative folding and subjected to a
reduction-pulse [(application of 2 mM DTTred for a period of 2 minutes) (9)], before addition of
glacial acetic acid (which reduced the pH to 3). Samples were desalted on a G-25 column prior to
application on a C-18 column for reversed-phase chromatographic analysis.
The rate of regeneration of the native protein (N) was determined by integrating the areas of
the peaks corresponding to the native protein (N), any structured intermediates (3S*) and the
fully-reduced protein (R) at each time point. The fractional increase in N was plotted as a
function of time; the data were fitted to a single-exponential function to obtain the rate constant
for the formation of N from R (20).
Impact of PDI on the rate-determining step (3S3S*) of RNase A regeneration.
Lyophilized 3S was introduced into a folding buffer (30 M protein, pH 8, 100 mM TrisHCl). Aliquots were withdrawn and subjected to the reduction-pulse at various time intervals
(13). The reaction was quenched and then analyzed by HPLC as described above (section 2.4). In
other experiments, the folding buffer contained either 4 M WT-PDI or its constructs. The rate
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of formation of 3S* was determined from analysis of the peak areas corresponding to 3S* and
3Snonnative (R) as a function of time, as described previously (20).
Preparation of 3Snative (an intermediate “poised-to-fold”).
Des [65-92 ]and Des [40-95] Ire obtained by strong cation-exchange fractional separation of
native RNase A that had been exposed to strongly reducing conditions as previously described
(I.e through reductive unfolding of the native protein) (6, 13). Des [65-72] and Des [40-95] were
separately collected and desalted on a reversed phase HPLC.
They were then lyophilized before being separately introduced into solutions of dilute acetic
acid (50 mM) as previously described to obtain unstructured Des (65-72) and unstructured Des
(40-95), respectively (13).
Impact of PDI and its domains on the structure-forming step of RNase A.
3Snative species (i.e., unstructured Des (65-72) and unstructured Des (40-95)) incubated at pH
2 in 50 mM acetic acid (and added HCl to bring the pH to 2) was introduced into a pH 8.2
solution (100 mM Tris-HCl, 1 mM EDTA) such that the final pH was 8 (30 M protein). One
minute later, the sample was subjected to a reduction pulse, as described above (section 2.4). All
samples were then desalted and analyzed by reversed-phase HPLC (C18 column; 1%/min
acetonitrile gradient).
The reduction pulse facilitates reduction of any unstructured intermediate such as unreacted
3Snative and its chemical isomerisation product (3Snonnative) to the fully-reduced protein (R) (6).
These can be easily separated on a reversed phase column as described above. The peak areas
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corresponding to 3S* and the fully-reduced protein (R) are integrated to obtain the fraction of
3Snative that was able to fold physically and form 3S*.
Percentage of 3Snonnative was calculated using the formula (12):
Percentage of 3Snonnative = 100 x [peak area (R)]/[peak area (R) + peak area 3S*].
Percentage of 3S* was determined by subtraction of percentage of 3Snonnative from 100.
In other experiments reduced wild-type PDI, null PDI or each domain (at 4 M, respectively)
was introduced into the pH 8.2 buffer, prior to introduction of the 3S species.
Measurement of the impact of PDI, null PDI and domains on the structure-forming step was
assessed by measuring the areas under the HPLC peaks corresponding to fully-reduced protein
(R) and the structured 3S* species as previously described (20, 21).

2.3 Results
Regeneration of RNase A.
The kinetic data pertaining to the regeneration of RNase A Ire fitted to a first-order rate
equation, ln (1-N) = -kt, where 1 - N is the fractional concentration of all nonnative species, k
represents the rate constant for the formation of the native protein, and t is the reaction time (20).
Figure 2.3 is a plot of the regeneration data of RNase A catalyzed by PDI and its sub-domains.
The data indicate that the regeneration rate is highest in the presence of WT PDI. For
comparison, an uncatalyzed regeneration profile (control) is also included () and is in good
agreement with previous reports (18).
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Figure 2.3. Plot of Ln (1-N) as a function of time. N is the fractional concentration of native
RNase A regenerated. The regeneration conditions were (a) pH 8, 50 mM DTTox, 20 mM TrisHCl, 1 mM EDTA, 25 oC for the control, ; b) control + 4 M PDI, ; c) control + 4 M null
PDI, ▲; d) control + 4 M ab, x; e) control + 4 M b’a’, ; and f) control + 4 M bb’ 
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Table 2.1 summarizes the rate-constants for the formation of the native protein as a
function of PDI or any added domain. The oxidative folding rate of RNase A (50 mM DTTox,
pH 8) is enhanced by the presence of composite ab and b’a’. At pH 8, a ~ 2.1-fold increase in
the rate of formation of the native protein is observed in the presence of ab (4 M) whereas a
1.5-fold enhancement is induced by b’a’, compared to the control. These values are relatively
low compared to catalysis by WT PDI (7.4-fold increase over the control). The addition of the
hydrophobic bb’ did not impact, within error, the oxidative regeneration of RNase A (Table 2.1).
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Table 2.1. Regeneration of RNase A (50 mM DTTox, 100 mM Tris-HCl, 1 mM EDTA, 25 oC)

Folding condition

Rate constant (pH 8)

Catalytic impact

pH 8

for RN (x104 min-1)

(Adjuvant/control)

R

11  0.5

-

R + 4M WT PDI

81.3  .4

7.4

R + 4M null PDI

11.2  0.1

1.02

R + 4 M ab

23  0.3

2.1

R + 4 M b’a’

16  0.25

1.45

R + 4 M bb’

10.3  0.7

0.93

Measurement of the impact of PDI on the rate-determining step (3S3S*) of RNase A
regeneration.
Table 2.2 lists the rate constants for the formation of 3S* species at pH 8 as a function of
added domain. WT PDI catalyzed the formation of 3S* from its 3S ensemble by a factor of ~11,
over the control (without PDI). The individual domains had lesser catalytic efficiencies; the ab
and b’a redox-active domains contributed approximately two-fold over the rate observed in the
uncatalyzed reaction. The bb’ domain does not appear to impact the reaction of the control
experiment.
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Table 2.2. Rate-constants (min-1) for the formation of 3S* species of RNase A from their
unstructured 3S isomers as a function of added PDI or PDI domain (4M, pH 8, 100 mM TrisHCl)
kf(Adjuvant)/kf(control)

akf [3S3S*]
Adjuvant

(-PDI)
(×103)

Control

1.6  0.2

-

WT PDI

18  0.7

11.25

Null PDI

2.1  0.4

1.3

ab

4  1.3

2.5

b’a’

3.2  0.3

2

bb’

1.75  0.4

1.1

Measurement of PDI and mutant variant impact on structure-forming step of disulfide-bondcontaining proteins.
Figure 2.4 depicts a typical HPLC chromatogram showing the formation of 3S* species and
3Snonnative from 3Snative (at a particular time along the reaction pathway; using Des (65-72)). The
peak labeled R corresponds to 3Snonnative. This is because the applied reduction pulse converts
unstructured intermediates to R (21).

34

60

R

mAU

40

3S*

20
0
-20
40

50

60

70

80

Time (mins)

Figure 2.4. Typical reversed-phase HPLC chromatogram (C18 column) showing results of the
competition between the structure forming step (3Snative3S*) and thiol-disulfide exchange
reactions (3Snative3Snonnative). Any 3S* formed by the physical conformational folding reaction
of 3Snative can easily be separated from the remainder of 3Snative that chemically reshuffles and
isomerizes to forms 3Snonnative and eventually populates all 419 unstructured isomers. This is
possible by the application of a reduction pulse that reduces any unstructured intermediate (such
as 3Snonnative and 419 isomers) to the fully-reduced protein (R). Reversed-phase HPLC is then
used to separate 3S* from R (formerly 3Snonnative and 419 unstructured isomers). The fraction of
3S* formed can then be quantified as described in Materials and Methods.
Table 2.3 summarizes the quantity of 3Snative species that conformationally folds to a stable
intermediate (3S* species). Note: the results Ire identical whether Des (65-72) or Des (40-95)
was used as the starting material. Hence, Des (65-72) was used because quantity in hand was
larger than the quantity of des (40-95) that was available. In the absence of any added PDI or
PDI subdomain, ~ 32% of the 3Snative species is able to conformationally fold to the stable 3S*
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intermediate, in agreement with previously reported literature (13). The addition of WT PDI
results in a large decrease in the amount of 3S* formed (eight-fold over the control). Similarly,
the rate of formation of 3S* by conformational folding of 3Snative is reduced addition of either ab
or b’a’ composite domains, although their ability to reshuffle 3Snative to 3Snonnative is diminished
relative to WT PDI. In contrast to these results, the addition of null PDI or the hydrophobic bb’
domain results in an enhanced conformational folding rate of the 3Snative species to 3S* relative
to the control that lacks PDI (40% and 38% respectively, relative to 32%).
Table 2.3. Measurement of oxidoreductase impact on structure-forming step of RNase A (pH 8,
100 mM Tris-HCl, 25 oC)

3Snonnative (%)

3S* (%)

-

68  1.7

32  1.4

WT PDI

96  2.2

4  1.2

Null PDI

60  0.7

40  0.34

ab

81  0.8

19  1.9

b’a’

79  0.67

21  0.89

bb’

62  2.3

38  1.22

Species
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2.4 Discussion
In vivo, oxidative protein folding takes place within the oxidizing environment of the ER
lumen (4). Within the ER environment, nature has invested in an oxidoreductase chaperone,
protein disulfide isomerase (PDI), which facilitates rapid exchange betIen thiols and disulfides
and catalyzes oxidative folding of “substrate” proteins (15, 23, 24).
However, during maturation of disulfide-containing proteins, the rate-determining step is
often a composite process comprised of chemical and physical half-processes (5-7). Furthermore,
the physical conformational folding reaction that is required for the generation of native (nativelike) structure competes with thiol-disulfide exchange reactions (such as reduction and/or
isomerization reactions) (Figure 2.2). The role of PDI in the pivotal conformational folding step,
which inherently competes with thiol-disulfide exchange, has heretofore not been explored.
In this study, I have examined the impact of PDI and its domains on the rate-determining step
in the regeneration of RNase A, with emphasis on dissecting its role in conformational folding of
RNase A and other disulfide-bond-containing proteins. Furthermore, I have also studied the role
of null and domains ab, b’a’ and bb’ in the RDS of RNase A oxidative regeneration. The ab and
b’a’ are composite in that they contain both redox-active and hydrophobic components and
permit “overall” assessment of mixed domain contribution to the structure-coupled step; bb’ is a
largely hydrophobic domain previously implicated in chaperone activity (17). This domain
permits assessment of the contribution of the hydrophobic domain of PDI to the rate-determining
and conformational folding steps.
The viability of each expressed domain was examined by evaluating its ability to regenerate
fully-reduced RNase A. Regeneration data of fully-reduced RNase A (Table 2.1) indicates that
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both composite domains are catalytically active in agreement with previous studies (19). Null
PDI and the hydrophobic bb’ domain does not significantly impact the overall oxidative folding
rate at both pH’s tested (Table 2.1). Taken together, the results obtained suggest that catalysis of
redox reactions play a greater role in facilitating oxidative folding than any “chaperone-like”
activity.
The roles of WT PDI and sub-domains in catalyzing the rate-determining step of RNase A
regeneration Ire next examined. Since the formation of 3Snative is mandatory to conformational
folding (species with nonnative disulfides do not acquire stable tertiary structure (5)), a catalyst
that can increase the frequency with which 3Snative forms from its unstructured isomers
(3Snonnative) would catalyze the overall formation of 3S* from 3Snonnative (the RDS). The
hydrophobic domains, along with null PDI, barely impact the RDS, suggesting that hydrophobic
interactions do not play a significant role in the RDS.
To investigate the role played by PDI and its domains in the pivotal structure-forming step of
the oxidative folding process I first populated a RNase A transient three-disulfide intermediate
containing only native disulfide bonds (3Snative) by pH denaturation of (native-like) structured
RNase A intermediates, Des [40-95] and Des [65-72] (13). This technique results in the
preservation of native disulfide bonds (by protonating cysteine sulfurs) while resulting in the
denaturation of the native-like des species. i.e. 3S* is converted to 3Snative at low pH and native
disulfide bonds are prevented from becoming reshuffled through intramolecular thiol-disulfide
exchange. Through this tool, the previously transient intermediate (3Snative) is now “frozen” and
amenable to further experimentation. Similarly, through analogous chemical tools I was able to
manipulate and trap ALAC and C65AC72A RNase A into states that are “poised-to-fold” (not
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shown). This biochemical inroad is critical to deconvoluting the physical folding step from the
chemical thiol-disulfide-exchange step in the RDS of oxidative protein folding.
In the absence of any added PDI/sub-domain, my data indicate that 30% of the 3Snative species
conformationally folds to form structured (native-like) 3S* species (Table 2.3). The remainder
back-reshuffles to 3Snonnative due to intramolecular attack by free cysteines on the native disulfide
bonds before the conformational folding reaction can lock in the native disulfide bonds within
stable tertiary structure. In the conformational folding of RNase A, proline isomerization is ratelimiting and hence back-reshuffling predominates (~70% of 3Snative is backreshuffled to
3Snonnative) (10, 13). The addition of WT PDI results in a drastic decrease in the percentage of
3Snative that can undergo successful conformational folding to form 3S* (Table 2.3). This is
because PDI cysteine’s accelerate the thiol-disulfide exchange betIen free cysteines of 3Snative
and its native disulfide bonds and convert native bonds to nonnative bonds. The PDI-facilitated
thiol-disulfide exchange outcompetes the conformational folding of 3Snative to 3S*. Hence, a
larger fraction of 3Snative is converted to 3Snonnative in the presence of PDI. The addition of null
PDI or the hydrophobic bb’ domain results in a slightly improved conformational folding rate as
evident from the percentage of 3S* formed (Table 2.3).
This may be due to binding of the hydrophobic bb’ domain to the unstructured 3Snative
species and stabilization of the unstructured intermediate in agreement with previous peptide
binding data which suggest that the bb’ domains are able to bind to unstructured peptides (17). In
conjunction with results obtained upon the addition of WT and null PDI, the addition of
composite ab and b’a’ domains confirmed that the redox-active domains have a higher impact on
back-reshuffling than the hydrophobic domain has on the forward rate resulting in a net loss in
formation of structured-intermediates in the presence of PDI.
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Importantly, my data demonstrate remarkable conflicting catalytic actions of PDI and its
domains on the pivotal structure-forming step which precedes maturation of disulfide-bondcontaining proteins. Although WT PDI facilitates oxidative folding and catalyzes the RDS, by
virtue of its redox-active domains it is highly detrimental to the forward folding reaction of those
species that are poised to conformationally fold (viz., RNase A 3Snative species). On the other
hand, null PDI and the hydrophobic bb’ domains bestow chaperone-like conformational folding
assistance during the structure-forming step (as seen in RNase A 3Snative species) even though
they do not have a significant effect on the overall regeneration rate and the RDS.
Notably, the highly evolved redox-activity of PDI, finely tuned to catalyze the highly redox
dependent oxidative folding process becomes self-limiting in the pivotal and mandatory
conformational folding event in oxidative regeneration. It overwhelms the promotion of the
forward reaction by the limited chaperone-activity demonstrated by the hydrophobic domains.
The impact of PDI on the various stages of oxidative folding is discussed, using the RNase A
regeneration pathway as a model.
Previous data have shown that PDI accelerates oxidation and isomerization reactions along
the regeneration pathway of ER-processed proteins (15, 16, 18). In this study, I demonstrate that
the oxidoreductase activity of PDI is instrumental in accelerating the RDS of RNase A
regeneration. However, I also observed that PDI hampers the conformational folding step, which
forms the latter half of the RDS. I.e. the ~11-fold acceleration in the RDS includes an observed
8-fold inhibition in the formation of 3S* due to back-reshuffling of species that are poised to
fold. The highly evolved oxidoreductase activity of PDI thus limits its full potential in catalyzing
the RDS and the overall oxidative folding rate. In other model folding scenarios involving
disulfide-bond-containing proteins, the presence of PDI was again detrimental.
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Chapter 3:
EF24 Intervention in Free-Radical Stress-Mediated Dysfunction of Protein Disulfide
Isomerase
3.1 Introduction
Oxidative folding of disulfide-containing proteins is a well-established method for
understanding protein folding mechanisms of disulfide-bond-containing proteins (1). Oxidative
protein folding comprises chemical and physical conformational changes which allow
construction of so-called disulfide folding pathway of a fully-reduced and denatured disulfide
bond-containing protein (2). Oxidative folding permits tracking and identification of partially
oxidized intermediates. This technique, first used in the study of bovine pancreatic trypsin
inhibitor (BPTI) and bovine pancreatic ribonuclease A, has been applied in elucidating the
folding pathway of numerous disulfide bond-containing proteins (2). It has long been studied as
a means to understand how the disulfide-bond reactions in proteins may be used to investigate
protein structure and stability, as well as the mechanism of protein folding (3).
Thiol/disulfide exchange is the prime chemical reaction involved in disulfide-bond studies in
which the thiolate anion R1S- displaces one sulfur of the disulfide bond R2SSR3 (4, 5); R1S- +
R2SSR3 → R2S- + R1SSR3 (Scheme 3.1). The formation and reduction of disulfide bonds
consisted by two such thiol/disulfide exchange reactions with a redox reagent, the first of which
involves the formation of a mixed disulfide bond between the protein and the redox reagent (3).
Thiol/disulfide exchange reactions can also occur intramolecularly; e.g., a protein thiolate group
may attack a disulfide bond of the same protein, leading to disulfide reshuffling (3).
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Scheme 3.1. Schematic diagram shows the activity of PDI on disulfide bond containing
model protein folding; (A) Isomerization activity of PDI; (B) Oxidation activity of PDI.

Since the chemical reaction of formation of disulfide bond mainly goes through the oxidation
of thiols, disulfide bonds can be formed spontaneously by molecular oxygen. For instance, under
aerobic conditions, a thin layer of cystine is generated at the air–liquid interface when a cysteine
solution is left exposed to air (6). However, this type of spontaneous, random air-oxidation
reaction is slow and insufficienct to meet protein throughput within a cell (6). This discrepancy
resulted in studies leading to the discovery of the catalyst for disulfide bond formation (6). The
search for enzymatic catalysts of oxidative refolding led to the finding of chief ER-resident
oxidoreductase chaperone, protein disulfide isomerase (PDI) (Scheme 1.3) (7). Intensive
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investigation of the activities of PDI in vitro has shown that the enzyme can catalyze the
oxidation or isomerization of disulfide bonds depending upon the redox conditions of the assay
and the nature of the substrate protein (8). PDI function is thus important role in regulating
traffic along the secretory pathway, for prevention of terminally misfolded proteins that would
otherwise constitute traffic along the retrotranslocatory pathway and mitigation of several
neurodegenerative diseases onset (9).
The activity of PDI mostly depends on two pairs of cysteines located within a domain
homologous (a and a' domains) to thioredoxin and each of which are found in the motif Cys-XX-Cys (10). The disulfide (oxidized) form of cysteines of PDI can transfer disulfide bonds
directly to substrate proteins, suggesting a physiological role for PDI as a protein dithiol oxidase.
However, when the active-site cysteines of PDI are present in dithiol (reduced) form, the enzyme
is suited for catalysis of disulfide reshuffling. The thiol/disulfide exchange ability of PDI also
leads the correction of incorrect disulfide bond formation (11).
Applications of disulfide-bond chemistry in studies of protein folding, structure, and stability
are highlighted and illustrated with α-Lactalbumin (α-LA) (Fig. 3.2). The general properties and
advantages of disulfide-bond studies have great impact on oxidative folding of α-Lactalbumin in
the structure formation during the regeneration of the native disulfide bonds. The structure of αLA consists of an α-helical and a β-sheet domain which are stabilized by by binding to calcium
ions (12-14). During the fold-maturation of α-LA, a partially folded intermediate α-LA-IIA is
generated which is capable of folding to form native α-LA (15). Reduced α-LA-IIA comprises a
structured β-sheet (calcium-binding) domain linked by two native disulfide bonds (Cys61-Cys77
and Cys73-Cys91) and an unfolded reduced-helical domain with four reduced free cysteines
(Cys6, Cys28, Cys111, and Cys120) (2).
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Figure 3.1. Diagram of EF24

Figure 3.2. Diagrams of α-lactalbumin, PDB: 1HFX, the yellow color representing the disulfide
bridges of the protein.
As the impact of ROS has been discussed on page 14, free radicals, such as peroxynitrite,
nitrogen dioxide, hydroxyl radicals have become immensely significant in recent (16). Free
radical NO* and *OH undergo variety of reactions including hydrogen atom abstraction from
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thiols (17). This free radical-based stress can induce posttranslational modifications, resulting in
overall conformational and structural changes in disulfide-bond containing proteins (18). It is
well-known that cysteine residues (Cys) in proteins are prominent targets for protein oxidation,
as they easily react with NO* and *OH free radicals. Oxidation of Cys by free radicals involves
nucleophilic attack of the cysteine thiol group on the electrophilic center of free radicals.
Deprotonation of the Cys thiol group to generate the thiolate anion increases its nucleophilicity,
and hence reactivity towards free radicals (Scheme 3.2) (18).
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Scheme 3.2. Schematic diagram shows thiol-disulfide exchange between α-Lac and PDI, αLac itself; (A) Free thiols of α-Lac and PDI are capable of thiol-disulfide exchange leads
oxidative folding of α-Lac, (B)Free radical stress on thiols causes hindrance in thio-disulfide
exchange between α-Lac and PDI leads polymerization of misfolded α-Lac and (C) Free
radical stress on thiols causes hindrance in thiol-disulfide exchange within α-Lac leads
polymerization of misfolded α-Lac.
In this dissertation I have exposed α-LA to NO* and *OH radicals during its oxidative
folding. I have found the formation of high molecular weight of polymeric α-LA. My data
confirms the hypothesis that free radicals cause hindrance in disulfide-bond mediated oxidative
protein folding by reacting with thiols (17). This ultimately results in aggregation of misfolded
proteins and polymer formation. Since PDI increases the rate of oxidative folding of disulfidebond containing proteins, I have also examined the catalytic activity of PDI under nitrosative
stress during the oxidative folding of completely reduced α-LA.
The present investigation also was designed to determine the ability of the polyphenol,
Diphenyl difluoroketone, (EF24, Fig. 3.1) to scavenge the free-radicals. Curcumin and
masoprocol have already been used clinically and approved by the FDA to scavenge excess ROS
and protects cysteinyl thiols from free radical stress (9) (Table 3.4). Currently, EF24 is being
used as an anticancer drug and found that EF24 is more efficacious and considerably less toxic
commonly used chemotherapeutic agent (19). My lab is investigating the reactive oxygen species
scavenging properties of EF24. In this study, I chose to assay the free radical scavenging
property of EF24 to prevent the chemical modification of thiols. My data show that EF24 can
scavenge the NO* and *OH by forming stable abducts. Thus EF24 can intervene in the ROS-
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induced misfolding of disulfide-bond containing proteins resulting in mitigation of misfolded
aggregates.
Human serum albumin (HSA) (Scheme 1.6) is a principal extracellular protein with a high
concentration in blood plasma and a carrier of many drugs and endogenous compounds to
different molecular targets (20, 21). The physical properties and possible binding domains are
discussed in introduction section (Reference 27, 28, 29 in introduction). In this study, the
spectroscopic analysis of HSA complexation with EF24 was carried out in aqueous solution at
physiological conditions, using constant protein concentration.

3.2 Materials and Methods
Reagents and cell line.
α-Lactalbumin (ALAC; >99.5% purity) was purchased from Sigma Chemical Co. (St. Louis,
MO, USA) and used without further purification. PDI was expressed and purified as previously
described (22). Reduced and oxidized dithiothreitol (DTTred and DTTox, respectively) Ire
purchased from Sigma Chemical Co and used without further purification. Protein ladder was
purchased from Fisher Scientific (PA, USA). EF24 was synthesized in collaboration with Dr.
Katja Michael (Dept. of Chemistry, UTEP) using a previously reported procedure (23). It was
further purified by HPLC and characterized by mass spectrometry. HPLC analysis of re-purified
EF24 showed purity ≥99%. Tetra-nitromethane (TNM) was obtained from Sigma-Aldrich (St.
Louis, MO., USA).
Characterization of NO* and *OH adducts of EF24.
A stock soln. of EF24 (prepared by weight in acetonitrile) was diluted to obtain
concentrations ranging from 10-200 µM (in acetonitrile). Tetranitromethane was added from a
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stock solution (freshly prepared by weight in acetonitrile) to EF24 so as to obtain different ratios
of NOx/EF24. EF24 was also exposed to Fenton reaction with 100 µM H2O2. The samples were
desalted and separated using reversed-phase HPLC (Supelco C18 column; 1% acetonitrile/min)
and collected peaks were lyophilized. The lyophilized peaks were analyzed on a Q-TOF mass
spectrometer.

Preparation of fully-reduced α-Lactalbumin (αLA).
Fully-reduced α-LA was prepared by incubating native protein (10 mg/ml) in 6 M Gdn- HCl
and 100 mM DTTred (pH 8, 100 mM Tris-HCl, 1 mM EDTA) for a period of 2 hours. The mixture
was then dialyzed three times against 50 mM acetic acid at 4° C prior to lyophilization. The
fully-reduced protein was dissolved into 10 mM acetic acid to obtain a stock solution (5 mg/ml)
that was kept frozen (-20°C) until further use.
Native gel electrophoresis.
Native gel 15% was prepared to run protein samples. Fully-reduced α-LA (36 M final
concentration) was incubated with oxidizing buffer (pH 8, 100 mM DTTox, 100 mM Tris-HCl,
25°C). Regeneration mixture was separately stressed by the addition of 100 µM TNM and 100
µM H2O2 via the Fenton reaction. Separate regeneration mixtures were seperately stressed under
the same conditions as above after preincubation with 300 µM EF24 to determine the effect of
EF24. All samples were collected after 5 hrs and run in 15% native gel.
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Densitometric analysis.

Densitometric analysis of all the bands formed in native-gel electrophoresis was done by
using Epi Chemi Darkroom, UVP imaging system in the Bio-core facility of Department of
Biological Sciences at UTEP.

PDI-catalyzed oxidative folding of α-LA under nitrosative stress and EF24.
Fully-reduced α-LA (36 µM final concentration) was incubated into a solution (pH 8, 100
mM DTTox, 100 mM Tris-HCl, 25°C) containing 4 µM of PDI and oxidative regeneration was
followed as previously described (24). A control experiment was separately performed without
the presence of PDI. Aliquots from the regeneration mixture were periodically withdrawn after
initiation of oxidative folding and subjected to a reduction pulse (application of 2 mM DTTred for
a period of 2 minutes), before addition of glacial acetic acid (which reduced the pH to 3).
Samples Ire desalted on a G-25 column prior to application on a C-18 column (Supelco
Discovery® BIO Wide Pore C18, 5 µM, 15cm x 100.0mm) for reversed-phase chromatographic
analysis using an acetonitrile gradient (1%/min) (9).
In other experiments, EF24 (8 µM final concentration from stock acetonitrile solutions
prepared by Iight) was incubated with the regeneration mixture prior to the addition of
tetranitromethane (6 µM obtained by dilution of the stock compound). The regeneration and
sample analysis was carried out as above. The rate of regeneration of the native protein (N) was
determined by integrating the areas of the peaks corresponding to the native protein (N),
structured intermediates and the fully-reduced protein (R) at each time point. The fractional
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increase in N was plotted as a function of time; the data Ire fitted to a single exponential function
to obtain the rate constant for the formation of N from R (9).
Preparation of stock solutions of HSA.
Human serum albumin, obtained from Sigma-Aldrich, was dissolved in aqueous solution (30
mg/40 ml or 13.4 uM) containing 200 mM Tris-HCl, 1 mM EDTA buffer (pH 8). The protein
concentration was determined spectrophotometrically using the extinction coefficient 39,900 M−1
cm−1 at 280 nm (25). Removal of any bound fatty acids to human serum albumin was carried out
using a charcoal treatment for 30 minutes followed by 10 minutes of centrifugation at max speed
(4000 rpm). EF24 [3,5-bis(2-flurobenzylidene)piperidin-4-one] 3 mM was first prepared in
water/ethanol 50% and then diluted to stock of 0.500 µM, 1 mM, and 2 mM in water/ethanol
50%.
Fluorescence spectroscopy.
Fluorimetry-based binding experiments were carried out on a DM-45 Spectrofluorimeter
(Olis). Titrations Ire conducted using 100 µL of ligand (500 µM, 1 mM, 2 mM, and 3mM) in 5
µL aliquot addition to 2.0 mL of HSA (Tris-HCL, pH8). The fluorescence spectra were recorded
at λexc = 280 nm and λem from 300 to 500 nm. For the fluorescence titrations, the observed
emission intensities were converted to a response factor, which is defined as the fractional
quenching (enhancement) between the free protein and the saturated 1igand: protein complex.
The data Ire fit to a simple hyperbolic binding model by nonlinearegression analysis using
DeltaGraph (Deltapoint, Inc, Monterey, California).
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3.3 Results
Ability of EF-24 to scavenge NO* and *OH radicals.
Mass-spectrometric analysis was performed to examine the ability of EF24 to form adducts
with NO* and *OH. Fig. 3A is a mass spectrum of EF24 prior to treatment with
tetranitromethane (MW 312 Da corresponds to protonated EF24). A mass addition of 45 Da to
EF24 post TNM treatment is indicative of nitration (Table 3.1). Note: addition of a nitro group
adds 46 Da. However, the nitro group replaces a hydrogen atom, resulting in the net addition of
45 Da. Further loss of a proton results in a MW of 356 Da. Fig. 3B is a mass spectrum of EF24
after it is exposed to Fenton chemistry with 100 µM H2O2. Mass addition of EF24 due to OH*
addition was characterized and reported (Table 3.1).
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Figure 3.3. (A) MS-QTOF of EF24 exposed to tetranitromethane. Mass addition (~45) indicates
the adduction of NO2 group to EF24; (B) MS-TOF of EF24 exposed to Fenton reaction. Mass
addition (~16) indicates the adduction of OH group to EF24
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Table 3.1. Adduct formation between polyphenol EF-24 with NO* and OH* (pH 8, 100 mM
Tris–HCl, 25°C).
Experimental conditions
EF24 (Control)
NO2+EF24
OH+O2-+ EF24

Mass (Da)+Identity
312.0649
312.0664
312.0664

Mass (Da)+Identity
---------356.1551
340.080

Analysis of polymerization of α-LA
Reduced α-LA was exposed to different conditions of ROS-stress (100 µM NO* or 100 µM
*OH). The sample was then analyzed by native gel electrophoresis. Densitometric analysis of all
the bands formed in native gel was done to quantify the polymer formation of α-LA under
different conditions (Fig. 3.5). My data demonstrate that high molecular weight of polymeric αLA was detected under NO* and *OH stress. Dimer, trimer and tetramer of reduced α-LA
protein were detected via gel seperation (Fig. 3.4).
In the absence of externally introduced free radicals, reduced and native proteins mostly
remain in monomeric form and ~11% of protein is found to be polymeric. Upon addition of *OH
and NO* radicals with reduced protein, polymer formation increases to a significant level (to
40% and 60%, respectively). In contrast, the addition of EF24 under ROS stress results in
increased levels of monomeric protein by mitigating the polymeric form. My data shows EF24
abrogates the *OH and NO*-induced polymerization by ~ 14% and ~57%, respectively.
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Figure 3.4. Native gel electrophoresis of α-lactalbumin protein shows polymer formation
under NO* and OH* stress. From left to right: lane 1-native α-LA; lane 2-reduced α-LA; lane
3- reduced α-LA exposed to Fenton reaction (produce *OH); lane 4- reduced α-LA exposed
to TNM (NO* donor); lane 5- reduced α-LA was exposed to Fenton after EF24preincubation; lane 6- reduced α-LA was exposed to TNM after EF24-preincubation. My
data reveals that preincubation with EF24 can rescue the polymerization of protein by
scavenging NO* and OH*. The diagram is a representative triplicate experiment and
experimental conditions are as decribed in the Methods section.
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Figure 3.5. Densitometric analysis of native gel electrophoresis of α-lactalbumin protein
shows high amount of polymer formation under NO* and OH* stress; preincubation with
EF24 can mitigate the amount of polymerization of protein by scavenging NO* and OH*.
Each bar represents average of triplicate values, and error bars their corresponding standard
deviation.

Regeneration of studies of α-LA by PDI.
The data pertaining to the regeneration of α-LA under select conditions of nitrosative stress
were fitted to a first-order rate equation, ln (1 -N) = -kt, where 1 – N is the fractional
concentration of all nonnative species, k represents the rate constant for the formation of the
native protein, and t is the reaction time (26). Table 3.2 summarizes the rate-constants obtained
for the formation of the native protein under the applied conditions. The relative fraction of
native protein formed as a function of time was plotted as a semi-log plot [ln (1-n) vs t]. The
rate-constant was calculated from the slope of each regeneration assay (not shown).
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Table 3.2. Regeneration of α-lactalbumin under control and NO* stress conditions (pH 8, 100
mM Tris-HCl, 25°C).
Reaction

Ratio

α-lactalbumin (30µM ALAC)

Rate constant
(min-1)
52.0±0.04×10-4

α-lactalbumin+ (4µM)PDI

183±0.25×10-4

3.51

With (4µM)PDI + (6µM) TNM

54.0±0.06×10-4

1.04

With (4µM)PDI + (8µM)
EF24)+(6µM) TNM

170.0±0.03×10-4

3.14

1

Figure 3.6 shows relative regeneration rates pertaining to the formation of native α-LA from
the fully-reduced protein. The addition of PDI (4 µM) to the regeneration mixture enhanced the
folding rate of the protein by ~3.5-fold over the control. However, the addition of NO* (6 µM)
resulted in reduced regeneration levels. The data also reveal that EF24 was able to rescue PDI
catalytic function to a significant level (~46%) under conditions of nitrosative stress. The
oxidative folding rate of α-LA (100 mM DTTox, pH 8) is enhanced by the presence of PDI (~183
×10-4 min-1 compared to ~52 ×10-4 min-1 for the control), but is diminished upon introduction of
6 µM TNM (~54× 10-4 min-1). The addition of the model NO* donor in the presence of 8 µM
EF24 resulted in a regeneration rate (~170 ×10-4 min-1) that was comparable to unmodified PDI.
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Figure 3.6. The protective effect of EF24 against NO* induced S-nitrosylation of PDI was
measured by using oxidative folding assay. From left to right, bar1, fully reduced α-lactalbumin
(R), control; bar2, (R), + 4 µMPDI; bar3, (R) + 4 µMPDI + 6 µM tetranitromethane; bar4, (R) + 4

µMPDI + 8 µM EF24+6 µM tetranitromethane. The regeneration conditions Ire 30 µM fullyreduced α-lactalbumin, 100 mMDTTox, pH 8, 20mMTris–HCl, 25°C.

Binding of EF24 to human serum albumin (HSA).
Figure 3.7 shows a typical intrinsic fluorescence emission intensity titration profile
(λexc = 280 nm and λem = 326 and 340 nm) for the binding of EF24 to HSA at pH 8. Based on
my spectroscopic results EF24 has very strong binding affinity toward HSA. EF24 shows high
affinity to HSA with consistent dissociation constants (Kd) of ~1.27 µM and ~1.37 µM when
repeated using independent and varying stock ligand concentrations (Table. 3.3).
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Table 3.3. Dissociation constant and summary of binding stoichiometries for the interaction of
EF24 and Human Serum Albumin (HSA) (200mM Tris-HCl, pH 8, 25°C)
Concentrations of EF24
(interacting with HAS)

Kd (µM)

Stoichiometry

500µM

1.27±0.63

1.6±0.21

1mM

1.37±0.45

1.4±0.14

Figure 3.7. Fluorescence emission profiles for the binding of EF24 (500µM-3mM) to native
human serum albumin (13.4µM) (A) Solid line represents a theoretical one-site binding profile.
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Fluorescence parameters Ire: λexc = 280 nm and λem = 326 and 340 nm from a scan over 300500 nm. All solutions Ire at 200 mM Tris-HCl, 1 mM EDTA, pH 8 and Ire prepared at room
temperature 24 ± 1 °C. Spectrometer conditions are noted in Materials and methods.

3.4 Discussion
Proteins that are destined for secretion typically required disulfide bonds formed through
oxidation of cysteines and rectified through thiol-disulfide exchange for their maturation and
biological function (28, 29). This takes place in ER. Proteins that do not fold or assemble
correctly are destined for degradation through retrotranslocatory pathway and subsequently get
aggregated in the cytosol.
The ER is a specialized compartment with a redox potential designed to facilitate the
(oxidative) formation of disulfide bonds in secretory or membrane-bound proteins (30). This is
an essential process preceding their export from the ER and is catalyzed by protein-disulfide
isomerase, the chief ER-resident oxidoreductase chaperone. The catalytic function of PDI,
executed through two redox-active cysteine-containing active sites is essential to balance the flux
betIen incoming nascent polypeptides and outgoing biologically viable folded proteins (30).
Compromise or failure in the catalytic efficiency of PDI can reduce the maturation of nascent
substrates and lead to terminal misfolding and retrotranslocation (30).
Previous studies have demonstrated that as a nucleophile, cysteines can be modified by
various electrophiles, thus participating in the regulation of protein function (31). Therefore,
protein post-translational modification involving cysteins have long been characterized as
important regulatory mechanisms for signal transduction. There are different types of redox-

59

related cysteine modifications including S-nitrosothiol (-SNO), sulfenic acid (-SOH), sulfinic
acid (-SO2H), and sulfonic acid (-SO3H) (31).
Here, I hypothesized addition of external NO* and *OH can react with cysteinyl thiolate (S-)
of reduced α-LA protein and leads to polymeric protein formation (via thiyl radical formation). I
have also hypothesized that EF24 can abrogate the aggregation of polymeric protein forms
through scavenging NO* and *OH radicals by forming stable adducts. Our previous study
demonstrated that polyphenol curcumin and masoprocol are capable of scavenging free radicals
and helps in oxidative protein folding (Table 3.4).

Table 3.4. Regeneration of RNaseA under control and NO* stress conditions (pH 8, 100 mM
Tris-HCl, 25°C).
Reaction
RNaseA (R) (30µM)

Rate constant for R→N
(× 104 min-1)
10.4±0.2

R+ (4µM)PDI=A

86.1±1.3

A+1µM TNM

35.5±2.6

A+2 µM TNM

19.7±0.4

A+4 µM TNM

11.3±2.1

A+4 µM TNM+ 30 µM curcumin

84.2±0.9

A+4 µM TNM+ 30 µM masoprocol

79.1±0.5
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To test my hypothesis, I first exposed EF24 to model NO* and *OH donor under in vitro
conditions. My data indicated the formation of nitrated and hydroxyl products suggesting that
EF24 was capable of scavenging NO* and *OH.
Next, I investigated the exposure of reduced α-LA to NO* and *OH. I found high molecular
weight of polymers when fully reduced α-LA was exposed to NO* and OH* donors. On the
other hand, protein pre-incubated with EF24 shows mitigated levels of polymerization. These
data support my hypothesis that EF24 can mitigate the aggregation of misfolded protein by
forming stable adducts with free radicals.
Since, PDI plays a crucial role in oxidative folding of disulfide-bond containing proteins by
assisting thiol-disulfide-exchange, I was interested in determining whether EF24 was capable of
rescuing PDI from nitrosative attack. In agreement with previous studies (9), my data reveal that
nitrosative stress results in the loss of PDI catalytic function; i.e., PDI-facilitated regeneration
rate of the well-known PDI substrate protein α-LA, in the presence of a model NO* donor,
reverts to values obtained in the absence of PDI, suggesting the loss of catalytic activity due to
modification of PDI active-site thiols by NO*. However, the observed rate of regeneration of αLA in the presence of PDI, NO* and EF24 equals levels observed with unmodified PDI (i.e., rate
observed in the absence of NO*). This indicates EF24 is able to scavenge elevated levels of NO*
and form stable adducts. Although the mechanism of action is not investigated here, my study
demonstrates that PDI function can remain unaffected under conditions of nitrosative stress as
long as scavenging EF24 is present. Altogether, my data suggest that EF24 can mitigate the
misfolded protein aggregation by preventing free radical mediated modification of PDI.
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Finally, I examined the binding affinity of human serum albumin (HSA) with EF24. My
results suggest that EF24 binds strongly to HSA suggesting that the protein could be a potent
carrier for EF24 from the site of absorption to tissues within the body.
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Chapter 4:
Prophylactic Effect of EF24 against Nitrosative Stress Induced Apoptotic Cell Death in PD
Model

4.1 Introduction
Among factors known to be associated with the etiology of apoptotic cell death, nitrosative
stress induced cell death by the excessive generation of NO* species has been demonstrated with
high importance in recent studies (1). However, the mechanism underlying this fact is still
unclear. Inhibition of the mitochondrial respiratory chain by rotenone has been widely used to
study the role of the mitochondrial respiratory chain in apoptosis (1). Recent evidence has
demonstrated that rotenone, a mitochondrial respiratory chain complex I inhibitor, could induce
cell-death in a variety of cells (2-6). Since it has been well-established that ROS play an
important role in apoptosis, the molecules that stimulate formation of ROS can cause apoptosis
(7, 8); a process likely to be inhibited by antioxidants (9-13). Mitochondrion-derived ROS are
vital not only because mitochondrial respiratory chain components are present in almost all
eukaryotic cells, but also because the ROS produced in mitochondria can readily influence
mitochondrial function without having to cope with long diffusion times from the cytosol.
Apoptotic stimuli instigate the release of cytochrome c from the mitochondrial inner
membrane space into the cytosol, where it triggers autocatalytic processing caspase-9 (21).
Caspase-3 gets activated along with other effector caspases by caspase-9, resulting in the
proteolytic cleavage of substrate nuclear poly (ADP-ribose) polymerase (PARP) (33).
Importantly, PARP cleavage is directly related to nitrosative stress-mediated cell-death along
with a variety of apoptotic responses (21).
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A hallmark event characteristic of neurogenerative disorders such as Lewy body dementia,
Alzheimer’s (AD) and Parkinson’s diseases (PD) is the accumulation of aggregated proteins to
form Lewy-bodies in the cytosol of human neuronal cells, which results in apoptotic cell death of
neuronal cells (14). This commonality exists in spite of the fact that causals for AD and PD are
different, depend upon whether familial or sporadic, and differ in the proteins constituting the
aggregates and Lewy neurites. There is also debate whether specific protein aggregates
representative of these diseases are truly the cause of the disease or only a mechanism to rescue
the cell upon onset of the neuronal pathology (14). Recent studies have demonstrated that in a
particular sporadic form of AD and PD, a key endoplasmic reticulum-resident oxidoreductase
chaperone protein disulfide isomerase (PDI) (Fig.3.1A) becomes chemically modified because of
high levels of nitrosative stress (14). A common feature observed in the neuronal cells of AD and
PD victims in this sporadic variant was the attachment of nitric oxide (NO) to the redox-active
cysteines of protein-disulfide isomerase (PDI) to form S-nitroso-PDI (Fig. 4.1). The formation of
S-nitroso-PDI coupled with the pathogenesis of AD and PD makes the oxidoreductase a chief
target for the prevention of these two neurodegenerative disorders in the nitrosative-stress-linked
variant of the diseases.
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Figure 4.1. Schematic representation of S-nitroso-PDI

The main objective of the present investigation was to determine the prophylactic ability of
the polyphenol, Diphenyl difluoroketone, (EF24, Fig.3.1B) in preventing ROS-associated PDI
dysfunction in cell lines using the aggregation of PD-specific biomarkers as evidence of ROSimpact on neuronal cells. My data reveal that EF24 can scavenge the excess NO* species and
prevent cells from rotenone induced apoptotic cell death.
Furthermore, it is known that during the nitrosative stress mediated apoptosis, Poly ADP
ribose polymerase (PARP) cleavage is associated with the rotenone induced ROS stimuli. PARP,
a 116 kDa protein, appears to be involved in DNA repair in response to environmental stress
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(15). Many ICE-like caspases are responsible to cleave this protein in vitro (16, 17) and PARP is
one of the main cleavage targets of caspase-3 in vivo (18, 19). In human PARP, the cleavage
occurs between Asp214 and Gly215, which separates the PARP amino-terminal DNA binding
domain (24kDa) from the carboxy-terminal catalytic domain (89kDa) (16, 18). PARP plays a
very crucial role to maintain cell’s viability; cleavage of PARP facilitates cellular disassembly
and serves as a marker of cells undergoing apoptosis (20, 21, 22). I have found that EF24 can
prevent the PARP cleavage significantly (Fig 4.7), mitigating rotenone-induced apoptotic stimuli
by scavenging excess reactive nitrogen species.
In this study I have overexpressed green-fluorescent protein tagged synphilin-1 in both
human neuronal (SH-SY5Y) and Porcine Aortic Endothelial (PAE) cell lines and monitored its
aggregation as a biomarker for PD. My results reveal that exposure of this cell line to rotenone, a
mitochondrial reactive oxygen species elevator, leads to the aggregation of synphilin-1 as
observed by fluorescence microscopy and consistent with previous reports that NO* influences
Lewy body formation via PDI modification (23). Importantly, cells that Ire preincubated with
EF24 prior to rotenone insult demonstrated a marked resilience to synphilin-1 aggregation. These
results suggest that it may be possible to mitigate nitrosative-stress induced aggregates in celllines using bioavailable polyphenolic phyto-analogs. Furthermore, it opens avenues for the
design and development of more effective and less toxic analogs prophylactics against
nitrosative-stress linked AD and PD.
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4.2 Materials and Methods
Reagents and cell line
EF24 was synthesized as mentioned in materials and methods section of chapter 3 (3.2). It
was further purified by HPLC and characterized by mass spectrometry. HPLC analysis of repurified EF24 showed purity ≥99%. Tetra-nitromethane (TNM) and rotenone (Obtained from
Sigma-Aldrich, St. Louis, MO., USA). Propidium iodide and annexin were bought from MP
Biomedicals, Solon, OH. Human PDI plasmid was generously provided by Dr. Lloyd Ruddock
(Department of Biochemistry, University of OULU, Finland), SHSY5Y and PAE cell line was
obtained from ATCC, Manassas, VA.

Preparation of fully-reduced RNase
Fully-reduced RNase A (R) was prepared by incubating native protein (10 mg/ml) in 6 M
Gdn HCl and 100 mM DTTred (pH 8, 100 mM Tris–HCl, 1 mM EDTA) for a period of 2 h (24).
The mixture was then repeatedly dialyzed against 50 mM acetic acid at 4°C prior to
Lyophilization. The “fully reduced” protein was dissolved into 10 mM acetic acid to obtain a
stock solution (5 mg/ml) that was kept frozen (-20°C) until further use.

PDI-catalyzed oxidative folding of RNase A under nitrosative stress
Fully-reduced RNase A (30 µM final concentration) was incubated into a solution (pH 8, 100
mM DTTox, 100 mM Tris–HCl, 25°C) containing 4 µM of WT PDI and oxidative regeneration
folloId as previously described (25, 26). A control experiment was run in parallel and did not
contain any PDI. Aliquots from the regeneration mixture were periodically withdrawn after
initiation of oxidative folding and subjected to a reduction pulse (application of 2 mM DTTred
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for a period of 2 min) (27), before addition of glacial acetic acid (which reduced the pH to 3).
Samples were desalted on a G- 25 column prior to application on a C-18 column (Supelco
Discovery®BIO Wide Pore C18, 5 lm, 15 cm ×100.0 mm) for reversed phase chromatographic
analysis using an acetonitrile gradient (1%/min) (25).
In other experiments, EF24 (8M final concentration from stock acetonitrile solutions
prepared by weight) were incubated with the regeneration mixture prior to the addition of
tetranitromethane (4M obtained by dilution of the neat compound). The regeneration and
sample analysis was carried out as above. The rate of regeneration of the native protein (N) was
determined by integrating the areas of the peaks corresponding to the native protein (N structured
intermediates and the fully-reduced protein (R) at each time point. The fractional increase in N
was plotted as a function of time; the data were fitted to a single exponential function to obtain
the rate constant for the formation of N from R (28).

Cell Culture
Porcine aorta endothelial (PAE) cells were cultured using Ham's F12 medium and
supplemented with 10% fetal bovine serum (FBS), 100U/ml of penicillin and 100 µg/ml of
streptomycin. SH-SY5Y cells were cultured with DMEM/F12 (1:1) medium and along with the
same supplements as was used for PAE cells. Cell lines Ire cultured around 70% of confluence
using tissue culture flasks (Falcon, Franklin Lakes, NJ). The incubation conditions of the cells
Ire at 37ºC in humidified 5% carbon dioxide (CO2) atmosphere.
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Cytotoxicity assay of EF24 in PAE cell
PAE cells were grown in 96-well plate and left to attach for 12 hrs. After 12 hrs, cells were
extensively washed with fresh media (formula of media mentioned in cell culture section, pg 69)
, to eliminate cell debris and floating cells which correspond mainly to dead cells; such wells can
introduce significant noise when used to perform cytotoxicity assays. Attached cells were treated
with 100 nM to 2 µM EF24 for 42 hrs and cytotoxicity of EF24 was monitored by using live-cell
imaging instrument.
Cytotoxicity assay and cellular protective effect of EF24 against rotenone aggression monitored
by using live-cell imaging instrument
Cell preparation
To prepare an experimental multiwell plate, cells were extensively washed with fresh media.
Adherent/live cell population were harvested by adding to the cells to 2 ml of 0.25% trypsin
solution (Invitrogen, Carlsbad, CA), diluted in serum free media, and incubated for
approximately 3 min at 37°C. After cell counting using Neubauer chamber (hemocytometer),
cells were seeded at density of 10,000 cells per well in 200 µl complete media utilizing 96 wellplate format.
Differential nuclear staining cytotoxicity assay
The protective effect of EF24 against rotenone-induced ROS insult was tested using PAE cell
lines. Cells in a multiwell plate prepared as described above were incubated for 12 h to allow for
attachment. Next, cells were previously pretreated with 1 µM of EF24 for 6 hrs prior to rotenone
exposed (100, 300, 500 nM and 1µM). Subsequently, cells were incubated for an extra 24 hrs and
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images were captured in live mode. Several controls were included in each experiment. As a
control for non-specific effects, the diluents of rotenone, EF24 and DMSO, as contained in the
experimental samples, was included at final concentration of 2.5 v/v.
Cells treated just with rotenone, without previous exposure to EF24, were tested at the same
concentration used in cells pretreated with EF24, to determine the cytotoxic effect of rotenone
itself. Also, cells were treated with 1 µM of EF24 alone, to determine its possible toxic effect.
Finally, untreated cells were prepared to determine the background levels of cell death, provoked
by cell manipulations and inherent features within the cell culture system.
In this study, automated microscopic imaging was used to ascertain cell death via the use of
a Differential Nuclear Staining (DNS). This mechanism has recently been validated as a high
throughput screening (HTS) assay (29). To each experimental and control well, a mixture of two
fluorescent dyes, Propidium iodide (PI) (MP Biomedicals, Solon, OH) and Hoechst 33342
(Invitrogen, Eugene, OR) at a final concentration of 1 μg/ml, were added 1h prior to image
recording. Both dyes are nucleic acids intercalators (29). Hoechst easily crosses cell membranes
of healthy and dead cells and stains nucleic DNA; However, PI is only capable of staining dead
cells with compromised plasma membranes. The fluorescence signal from each individual
fluorophore emitted by stained cells was captured in two separate channels, in fulfillment with
the dye emission requirements. Images were acquired directly from a tissue culture mulitiwell
plate utilizing a BD Pathway 855 Bioimager system (BD Biosciences Rockville, MD). To
acquire adequate numbers of cells for statistical analysis purpose, montages (3X3) from nine
adjacent image fields were captured per well, utilizing a 20X objective. Captured images and
data analysis determining the percentage of dead cells from each individual well was performed
by using BD AttoVision™ v1.6.2 software (BD Biosciences Rockville, MD), designed to assist
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the Bioimager system. Every experimental point, as well as all controls, was assessed in
quintuplicate.

Apoptosis/Necrosis Assay
PAE cells were seeded on 24-well microplate at density of 20,000 cell/well in 1ml of media
and cultured at 37°C under 5% CO2 humidified atmosphere. Cells were incubated overnight to
promote adherence, followed by 6 hrs preincubation in presence of 1µM EF24 and then added
with 500 nM rotenone and incubated for additional 48h. Cells from each individual well were
collected, washed and processed essentially as previously described (30). Briefly, cell were
concurrently stained by resuspending them in a solution containing Annexin V-FITC and PI
dissolved in 100 μl of binding buffer (Beckman Coulter, Miami, FL). After incubation for 15
min on ice in the dark, ice-cold binding buffer (400 μl) was added to the cell suspensions, gently
homogenized, and immediately analyzed by flow cytometry. For each sample, approximately
10,000 individual events were acquired using flow cytometer (Cytomic FC 500; Beckman
Coulter, Miami, FL) and data analyzed with CXP software (Beckman Coulter, Miami, FL).
Every experimental point, as well as all controls, was assessed in quintuplicate.
Western blotting
Total cell lysates were prepared by washing the cells with cold Tris-buffered saline, collected
by centrifugation (3003g, 5 min at 48°C, and extracted by sonicating in buffer containing 10 mM
Tris–HCl (pH 7.4), 10 mM EDTA, 2% (w/v) SDS and protease inhibitors (Sigma). Total protein
concentrations were measured using a bicinchoninic acid kit (Pierce) and BSA as standard. Equal
amounts of protein (approximately 10 µg per lane) were separated using SDS-polyacrylamide
71

gel electrophoresis and then transferred to polyvinyldifluoride (PVDF) membranes. Blots were
incubated in blocking buffer (5%, w/v, dried skimmed milk in Tris-buffered saline, pH 7.4, and
0.1% TIen 20) folloId by incubation anti-PARP rabbit polyclonal antibody (1:1000, Cell
Signaling Technology®) or anti-GAPDH (Glyceraldehyde 3-phosphate dehydrogenase, 1:1000
dilution) diluted in blocking buffer for 1 h then with horseradish peroxidase (HRP)-conjugated
goat anti-rabbit (KPL Biomedical) in 1% BSA/TBST for 30 min. Chemiluminescence (ECL-plus
or SuperSignal west Pico Chemiluminescent Substrate) was used according to the
manufacturer’s instructions (Amersham or Pierce Biotechnology Inc.).

Cloning of synphilin-1 and expression of EGFP- synphilin -1 fusion proteins
The full-length cDNA of the human synphilin-1 (Genbank accession code; NP 005451) was
amplified via PCR, using as template pENTR 221 (Invitrogen). The primer set was designed to
contain EcoRI in forward and BamHI in reverse restriction enzyme cleavage sites, providing
directionality for cloning purposes into pEGFPC2 expression vector (Clontech. Palo Alto, CA);
forward,

5’-aaatttgaattcatggaagcccctgaataccttgatttg-3’

and

reverse,

5’-

aaatttggatccctacaagaagagttcttttgactc-3’; (underlined segments represent EcoRI and BamHI sites,
respectively). PCR-amplified products were separated using 1% agarose gel stained with
ethidium bromide, gel purified (QIAEX II, Qiagen, Valencia, CA) and verified by DNA
sequencing reaction. After double digestion of purified amplicons with EcoRI and BamHI, the
digested fragments were separated and purified as mentioned above and cloned into pEGFP-C2
expression vector (Clontech. Palo Alto, CA), previously digested with the same set of restriction
enzymes used for the insert. After ligation and transformation reaction, a colony was selected,
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its plasmid isolated and its insert sequenced, corroborating to correspond to the synphilin-1 gene.
This pEGFP-C2; synphilin-1 construct was utilized to transiently transfect PAE mammalian cell.
Transfection and cell treatment
SH-SY5Y and PAE cells (1×106 cells/well) were seeded onto glass coverslips in 6-well plates
and incubated at 37 °C in 5% CO2 for 12-16 h. Cell transfections were performed next day as
(recommended by manufacturer) using effectene reagent (Qiagen, Valencia, CA). Cells were then
incubated with transfection complexes under normal growth condition for expression of pEGFPC2 control or the fusion protein GFP-synphilin-1 gene. Transiently transfected SH-SY5Y and
PAE cells were incubated overnight to allow expression of proteins. Cells were treated with
DMSO vehicle or with 1 µM EF24 for 6 hrs followed by exposure to 300 nM of the toxicant
rotenone for 12 hrs. After attachment, cells were prepared for microscopy as described below.
Confocal microscopy and immunocytochemistry
Cells transfected with EGFP-synphilin-1 fusion proteins were washed after treatments, fixed
with 4% paraformaldehyde in PBS, stained with DAPI and mounted under ProLong antifade
medium (Molecular Probes). To stain for PDI, cells were fixed as above, then permeabilized with
0.1% (w/v) saponin in PBS, blocked with PBS plus 5% goat serum, 5% FBS and 0.1% Tween 20,
and incubated with primary antibody (overnight at 4ºC) folloId by incubation with rhodamineconjugated goat anti-mouse (1:10000, KPL Biomedical), and DAPI staining. Fluorescence
confocal images were captured utilizing LSM 700 confocal microscope (Zeiss. New York. NY)
with 63X objective and assisted with ZEN 2009 software (Zeiss. New York, NY).
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4.3 Results
Ability of EF-24 to scavenge NO*
The ability of EF-24 to scavenge NOx from TNM was re-established and results obtained
were similar to that described in Chapter 3.

Regeneration of studies of RNase A by human PDI
Fig. 4.2A shows the regeneration profile of fully-reduced RNase A. The kinetic data (Fig.
4.2A) pertaining to the regeneration of RNase A under select conditions of nitrosative stress
were fitted to a first-order rate equation, ln (1-N) = -kt, where 1-N is the fractional concentration
of all nonnative species, k represents the rate constant for the formation of the native protein, and
t is the reaction time (30). The addition of human PDI (4 µM) to the regeneration mixture
enhanced the folding rate of the protein by ~4-fold over the control (Fig 4.2B). However, the
addition of NO* (4 µM data shown) resulted in reduced regeneration levels. The data also reveal
that EF24 was able to rescue PDI catalytic function to a significant level (86%) under conditions
of nitrosative stress. Table 4.1 summarizes the rate-constants obtained for the formation of the
native protein under the applied conditions. The oxidative folding rate of RNase A (100 mM
DTTox, pH 8) is enhanced by the presence of PDI (~112 ×10-4 min-1 compared to ~27 ×10-4 min1

for the control), but is diminished upon introduction of 4 µM TNM (~39× 10-4 min-1). The

addition of the model NOx donor in the presence of EF24 resulted in a regeneration rate (~85
×10-4 min-1) that was comparable to unpoisoned PDI.
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Figure 4.2. The protective effect of EF24 against rotenone induced S-nitrosylation of PDI was
measured by using oxidative folding assay. (A) Regeneration of native RNase A formed from the
fully-reduced protein (R). ○, control; ×, + 4 µM PDI; □, + 4 µMPDI + 4 µM tetranitromethane;
∆, + 4 µMPDI + 8 µM EF24; ◊, + 4 µMPDI + 8 µM EF24+4 µM tetranitromethane; The
regeneration conditions were 30 µM fully-reduced RNase A, 100 mMDTTox, pH 8, 20mMTris–
HCl, 25°C. (B)The rate constant and ratio of regeneration of RNaseA under same conditions are
shown in bar diagram.
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Table 4.1. Regeneration of RNase A under control and nitrosative stress conditions (pH 8, 100
mM Tris-HCl, 25 °C).

Rate constant for R→N (×10-4 min-1)

Folding condition

R

27±0.2

R+4µM PDI

112±0.9

R+4µM PDI+4µM TNM

39±2.1

R+4µM PDI+8µM EF24

108±2.6

R+4µM PDI+8µM EF24+4µM TNM

85±1.2

R- Reduced RNaseA with oxidizing buffer (Control)
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Differential nuclear staining assay to quantify cytotoxicity
The Differential nuclear staining assay revealed that rotenone increased cytotoxicity level in
the presence of rotenone. The increase of cytotoxicity by rotenone insult was measured in a dosedependent manner. Survival and death of PAE cells were simultaneously visualized by using a
live/dead assay (Fig. 4.3). Treatment with 1µM EF24 lowered the level of cytotoxicity (Fig. 4.4).
Dead cells, which were detected as red in fluorescence, apparently increased in number after
rotenone exposure. A low concentration (100nM) of rotenone does not significantly increase
cytotoxicity,

but

gradual

increase

in

the

concentration

of

rotenone

(100nM→300nM→500nM→100nM) results in increased cytotoxicity. My data indicate 80%
toxicity at 1000nM rotenone after 24 hrs incubation. Pre-treatment with 1µM EF24 for 6 hMys
reduces the amount of cytotoxicity to a significant level (≥50%).
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Figure 4.3. Cytotoxicity was monitored by using differential nuclear staining assay on PAE
cells. Representative images of cells treated with 300 nM of rotenone. The four images
correspond to the same portion of the 3X3 montage, captured with 20X objective utilizing BD
Pathway Bioimager system and AttoVison software. Due that the BD Pathway system is
equipped with monochrome Hamamatsu camera (black and white) and it was necessary to apply
computerized (AttoVision sofware) pseudocolor to each fluorescence channel to achieve colored
image. (A) Hoechst emission signal (excitation/emission maxima: 460/490 nm) from stained
cells indicates the total number of nuclei (cells) present in the image, shown in blue. (B)
78

Propidium iodide emission signal (excitation/emission maxima: 535/617 nm) from labeled cell
nucleus indicates the number of death cell in the image, shown in red. (C) Segmented image,
showing regions of interest (ROI) utilized in the image analysis procedure, where nucleus of
propidium iodide positive cells (death) appears in red, whereas nucleus of live cells are delimited
by a white line. (D) Merged Hoechst and PI image, from signals of the two fluorescence
channel; the magenta color is an outcome of colocalization of red and blue colors, indicating the
number of death cells in the image. AttoVision software assigns a number to each ROI, which is
annotated in the image (D).
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Figure 4.4. The prophylactic effect of EF24 against rotenone aggression was tested utilizing
PAE cell line, measured by using differential nuclear staining cytotoxicity assay. Cells were
pretreated with 1 µM of EF24 for 6 hrs and exposed to several concentrations (100, 300 500
and 1000 nM) of the toxicant rotenone for another 24 hrs. Three controls were included:
cells treated with several concentration of just rotenone, 100, 300 500 and 1000 nM; cells
treated with 2.5% v/v DMSO, as contained in the experimental samples: and untreated cells,
as a control for non-specific effects. Each bar represents average of triplicate values, and
error bars their corresponding standard deviation.
Apoptosis/Necrosis Assay
Fig. 4.5 shows the representative dual parameter flow cytometric histograms of the
apoptosis/necrosis effects caused by EF24 (panel A), rotenone (panel B) and pretreated PAE
cells with EF24/rotenone (panel C) treatments. Representative histograms of controls are also
included; panel D, untreated cells; panel E, cells treated with DMSO; and panel F, cells treated
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with H2O2 as positive control for apoptosis. The concentrations utilized are annotated on the top
of each histogram. Each histogram is fragmented in four quadrants. Left top quadrant – necrosis,
cells permeable to propidium iodide that lost their membrane integrity, without Annexin V-FITC
signal, one color (red); right top quadrant - late apoptosis, cells with compromised plasma
membrane, permeable to propidium iodide, but also with Annexin V-FITC signal, two colors
(green and red); lower left quadrant - alive unstained cells, without propidium iodide or Annexin
V-FITC fluorescent signal; lower right quadrant-early apoptosis, cells with only Annexin VFITC signal, one color (green). Approximately 10,000 events were acquired per each individual
sample and analyzed using CXP software (Beckman Coulter).
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Figure 4.5. Representative two parameters flow cytometric histograms of the apoptosis/necrosis
effects caused by EF24 (panel A), rotenone (panel B) and pretreated cells with EF24 /rotenone
combinatorial (panel C) treatment on PAE cell line.

The prophylactic effect of EF24 against rotenone-induced toxicity in PAE cells was
evaluated using flow cytometry. Cells were simultaneously stained with Annexin V-FITC and
PI, after 48 hours of incubation, and the total percentage of apoptotic cells were expressed as the
sum of both early and late stages of apoptosis (white bars) (Fig. 4.6). Cells permeable to
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propidium iodide without Annexin V-FITC signal were considered as necrotic cells (black bars).
Cells treated with H2O2 were utilized as positive control for apoptosis. The diluent of EF24 and
rotenone, DMSO, was evaluated at the same concentration as included in the experimental
samples, as a control for nonspecific diluent activities. Untreated cells were used as an indicator
of overall cell viability. Results show that rotenone induced excessive generation of NO* leads
cell death primarily via the apoptotic pathway. Necrotic cell death due to rotenone aggression
was very low compared to control. My data also reveal that EF24 can mitigate the effect of
nitrosative stress and prevent the apoptotic cell death.

Figure 4.6. The protective effect of EF24 against rotenone induced apoptotic and necrotic cell
death in PAE cell line was measured by using double staining with Annexin V-FITC/ propidium
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iodide and monitored via flow cytometric assay. Cells were pretreated with 1 µM of EF24 for 6
hrs and exposed to 500 nM of the toxicant rotenone for an extra 42 hrs. Also as controls, cells
treated just with 500 nM rotenone, 2.5% v/v DMSO, 1µM EF24 were included. As a control for
non-specific effect, untreated cells were also included. Each bar represents average of triplicate
values, and error bars their corresponding standard deviation.

PARP assay
PARP serves as a marker of cells undergoing apoptosis. PARP assay has been done to
support the fact that rotenone induced nitrosative stress stimuli can lead cells to mostly apoptotic
cell death over necrotic cell death. My data show 300 nM rotenone stress on cells for 42 hrs
increases cleavage of PARP level over control (4.7). Excess generation of NO* facilitates to
separate the PARP carboxy-terminal catalytic domain (89kDa) from amino-terminal DNA
binding domain (24kDa), which activates the apoptotic pathway. My data also show cells
pretreated with 1µM EF24 can prevent nitrosative stress induced PARP cleavage (4.7). EF24 can
scavenge the excess NO* and acts as a prophylactic by mitigating the apoptotic stimuli.
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Figure 4.7. Protective effect of EF24 against rotenone induced poly (ADP-ribose) polymerase
(PARP) cleavage, marker of apoptosis progression, in PAE cells. PARP cleavage was analyzed
via Westernblot analysis (n=1). Whole cell protein extracts were separated using polyacrylamide
gel electrophoresis and transferred to a polyvinylidene fluoride (PVDF) membrane, followed by
immunoblot analysis utilizing antibodies anti-PARP. Four cell extracts were prepared from:
untreated control PAE cells, lane C; cells treated with 1µM of EF24 for 48 h, lane 1; cells treated
with 300 nM of rotenone for 42 h, lane 2; and cells pretreated with 1 µM EF24 for 6 hrs followed
by addition of 300 nm rotenone and secondary incubated for 42 h,

lane 3. The band

corresponding to intact PARP protein (116-kDa) is delineated with blue rectangle in Lane C
(top). Also in Lane C, the cleavage product of PARP (89-kDa) is delineated with a red rectangle
(bottom). Position of protein markers in kDa are annotated to the left of the blot.
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S-nitrosylation of PDI mediates synphilin-1 aggregation in model cells of PD
Fig. 4.8 (panels A through E) is a set of confocal microscopy images of GFP-tagged
synphilin-1 expressed in transiently transfected PAE cells as a function of different conditions.
The results clearly indicate the aggregation of synphilin-1 when exposed to 300 nM rotenone
(panel A). As compared to this, pre-treatment of cells with 1 mM EF24 prior to 300 nM rotenone
exposure resulted in a markedly diminished level of synphilin-1 aggregation (as evidenced
through GFP fluorescence; panel B). Other experiments revealed a relatively homogeneous
cytosolic distribution of GFP in cells transfected with pEGFP C2 plasmid alone (panel C). In
contrast, cells transfected with EGFP- synphilin-1 constructs show a punctuated (or speckled)
cytosolic distribution of green fluorescent signal (panel E). This observation indicates that over
expression of synphilin-1 fused to EGFP protein, provided subcellular accumulation of the
recombinant fusion protein, called aggregosomes. Cells, treated with the vehicle alone (DMSO;
Fig. 4.8D) did not differ in the expression of EGFP-synphilin-1 as compare to untreated cells
(Fig. 4.8E).
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Figure 4.8. Effect of EF24 and rotenone on synphilin-1 distribution in PAE cell. Confocal
microscopy images of PAE cells reveal the presence of intracellular aggregates in cells
transfected with EGFP-tagged synphilin-1. Transfected PAE cells were DMSO treated or
stressed with rotenone and stained by immunofluorescence as detailed in the Materials and
methods section. (A) Cells exposed to 300 nM rotenone for 12 h alone, (B) or pretreated with 1
µM EF24 following treatment with 300 nM rotenone. Controls were (C) cells transfected with
vector pEGFP-C2, (D) Cells transfected with pEGFP-tagged synphilin-1 construct and treated
with DMSO 2.5 v/v and (E) untreated. Nucleus was stained with DAPI, (blue color). White
arrows indicate the presence of aggregates corresponding to the recombinant fusion protein.
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In summary, these results showed that cells treated with rotenone induced nitrosative stress
apparently increased the green fluorescence protein fused to synphilin-1 (or EGFP-synphilin-1)
by forming cytosolic inclusion bodies, whereas pre-treatment with 1 µM EF24 mitigated the
aggregation of the fused EGFP-synphilin-1 to a significant levels. Figure 4.9 represents similar
results in SH-SY5Y cell. I have performed this experiment in human neuronal SH-SY5Y cell
line with similar conditions to the experiment in PAE cell line. My data reveal pre-treatment of
SH-SY5Y cells with 1 mM EF24 prior to 300 nM rotenone exposure resulted in a markedly
diminished level of synphilin-1 aggregation.

88

Figure 4.9. Effect of EF24 and rotenone on synphilin-1 distribution in SHSY5Y cell. Confocal
microscopy images of SHSY5Y cells reveal the presence of intracellular aggregates in cells
transfected with EGFP-tagged synphilin-1. Transfected PAE cells were DMSO treated or
stressed with rotenone and stained by immunofluorescence as detailed in the Materials and
methods section. (A) Cells exposed to 300 nM rotenone for 12 h alone, (B) or pretreated with 1
µM EF24 following treatment with 300 nM rotenone. Controls were (C) cells transfected with
vector pEGFP-C2., (D) Cells transfected with pEGFP-tagged synphilin-1 construct and treated
with DMSO 2.5 v/v and (E) untreated. Nucleus was stained with DAPI, (blue color). White
arrows indicate the presence of aggregates corresponding to the recombinant fusion protein.

Figure 4.10A is a SDS-gel confirming expression of human-PDI in E. coli and Figure 4.10B
is a confocal microscopy image confirming that PDI is expressed at a high level within the PAE
cells and localized mostly in the endoplasmic reticulum and to a much lower level in the cytosol
in PAE cells.
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10 µm

Figure 4.10. Expression of human PDI (57kDa) in bacterial (A) and mammalian (B) cells.
Partially Ni-NTA-purified column protein extracts from selected colony of transformed E. coli
competent cells expressing human PDI were separated using polyacrylamide gel electrophoresis
and stained with Coomassie brilliant blue (A): lane M, protein markers; lane 1, elution 1 with
200 mM imidazol and lane 2, elution 2 with 300 mM imidazole. Representative confocal image
of transfected PAE cell expressing human PDI (57kD) (B); white arrow indicate the presence of
PDI mainly in the cytosol, confirmed by immunocytochemistry using PDI antibody (red
fluorescence signal); cell nuclei was counterstained with 4',6-diamidino-2-phenylindole (DAPI),
shown in blue color.
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Figure 4.11. The effect of EF24 on PAE cell line, (A) the bar diagram shows effect of EF24 with
different concentrations from 100 nM to 2µM (B) the line diagram shows effect of EF24 with
different concentrations from 100 nM to 2µM. Control is the untreated cells.
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Dose response assay of EF24
Figure 4.11A and 4.11B show the dose response assay of EF24 in PAE cell line. My
data reveals EF24 shows no cytotoxicity at 1µM, but it is cytotoxic at 2 µM concentration.
Therefore, I have selected 1µM of EF24 to perform my assays in cell.

4.4 Discussion
The mitochondrial respiratory chain (complexes I-V) is the major site of ATP production in
eukaryotes (31). Rotenone, inhibitor of the mitochondrial respiratory chain, has been widely used
to study the role of the mitochondrial respiratory chain in apoptosis. Recent evidence has
demostrated that rotenone leads to apoptotic cell death (mechanism is discussed in introduction
section, pg 64).
Here, I hypothesized that the bioavailable EF24 can diminish the chances of apoptotic cell
death through mitigating nitrosative stress by scavenging excess NO*. To test my hypothesis, I
first exposed EF24 to a model NO* donor under in vitro conditions. My data indicated the
formation of a nitrated product suggesting that EF24 was capable of scavenging NO* as a free
radical scavenger. Next, I determined whether EF24 was capable of rescuing human PDI from
nitrosative attack with in vitro study. In agreement with previous studies, my data reveal that
nitrosative stress results in the loss of PDI catalytic function (32). i.e., PDI-facilitated
regeneration rate of the well-known PDI substrate protein RNase A in the presence of a model
NO* donor reverts to values obtained in the absence of PDI, suggesting the loss of catalyst
activity due to modification of PDI active site by NO*. However, the observed rate of
regeneration of RNase A in the presence of PDI, NO* and EF24 equals levels observed with
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unmodified PDI (i.e., rate observed in the absence of NO*). This indicates EF24 is able to
scavenge elevated levels of NO* and form stable adducts. Although the mechanism of action and
location NO* on the polyphenol is not investigated here, my study demonstrates that PDI
function can remain unaffected under conditions of nitrosative stress as long as scavenging EF24
is present.
Here, I determined whether EF24 was capable of mitigating nitrosative stress by scavenging
excess generation of NO* in cell lines. By using PAE cell line, I investigated the cytotoxicity of
rotenone and prophylactic effect of EF24 against rotenone through differential nuclear staining
cytotoxicity assay. Although I was unable to detect the mechanism of cell death (Apoptotic or
necrotic) by this assay, my study shows that rotenone induced cytotoxicity reduced to a
significant level in the presence of EF24.
My next study was to determine whether rotenone induced nitrosative stress leads cell death
through apoptotic or necrotic pathways. I used flowcytometric assay to determine the pathway of
rotenone induced cytotoxicity in PAE cell line and prophylactic affect of EF24 against rotenone
induced nitrosative stress related apoptotic or necrotic cell death. My data demonstrated that
rotenone causes cytotoxicity in PAE cell line mostly through the apoptotic pathway and EF24
administration reduces the apoptotic cell death significantly by mitigating nitrosative stress.
I have also done PARP analysis to confirm rotenone induced nitrosative stress leads cell
death essentially through apoptotic pathway. Excessive generation of NO* by mitochondrial
complex-I inhibitor rotenone leads PARP cleavage via caspase activity which in turn activates
apoptotic stimuli in eukaryotic cell. I determined that rotenone induced PARP cleavage is
reduced significantly in the presence of EF24. This suggests that EF24 can prevent ROSdependent apoptotic cell death.
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Taken together I conclude that rotenone activates activates the programmed cell-death stimuli
and results in apoptotic cell death via caspase-9 and caspase-3 activation→PARP
cleavage→DNA fragmentation; EF24 acts as a prophylactic against rotenone induced nitrosative
stress related apoptotic cell-death.
Scheme 4.1 is the representative model, which shows the effect of PDI in Ubiquitin Protease
System (UPS) of a cell. Recent studies showed that brains manifesting sporadic Parkinson’s or
Alzheimer’s disease, that PDI is S-nitrosylated, a reaction transferring a nitric oxide (NO) group
to a critical cysteine thiol to affect protein function (22). Nitrosative stress induced Snitrosylation of PDI inhibits its enzymatic activity, leads to the accumulation of
polyubiquitinated proteins, and activates the unfolded protein response. S-Nitrosylation also
abrogates PDI-mediated attenuation of neuronal cell death triggered by ER stress, misfolded
proteins or proteasome inhibition. Thus, PDI prevents neurotoxicity associated with ER stress
and protein misfolding, but NO* blocks this protective effect in neurodegenerative disorders
through the S-nitrosylation of PDI, which opens up the pathway of apoptotic cell death.
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Scheme 4.1. A representative model shows how PDI plays a vital role in Ubiquination protease
system and nitrosative stress induced S-nitrosylation leads to apoptotic cell death.
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Finally, I examined the impact of cytosolic aggregation of synphilin-1 in the SHSY5Y and
PAE cell line under rotenone-induced nitrosative stress as previously demonstrated (22). GFPlabeled synphilin aggregation was monitored using confocal microscopy. In comparison to
control experiments, incubation of the cell line with rotenone clearly demonstrated cytosolic
aggregation of synphilin-1 consistent with previous results suggesting that healthy PDI inhibits
aggregation of synphilin-1 (22). As one of the controls, I tested whether unstressed cells
expressing PDI could prevent synphilin-1 constituted Lewy-body-like inclusions that can be
formed in the cytosol after synphilin-1 overexpression (22). My data revealed very limited
diffused synphilin-1 localization in cytosol (Fig. 4.8E and 4.9E). In contrast, rotenone treated
cells showed discrete inclusions of synphilin-1 in the cytosol. These results suggest that
rotenone-dependent elevation of nitric oxide attenuated the protective effect of PDI on synphilin1 inclusions (Fig. 4.8A and 4.9A).
Next, cells were preincubated with EF24 prior to rotenone exposure to determine whether
EF24’s NO* scavenging ability demonstrated in vitro could be translated inside the cell.
Confocal microscopy data monitoring GFP-tagged synphilin-1 clearly indicate that unlike
rotenone-induced nitrosative stressed cells (Fig. 4.8A and 4.9A), cells pre-treated with EF24
followed by rotenone treatment showed a drastic decrease in discrete Lewy-like inclusions in
cytosol (Fig. 4.8B and 4.9B). These results suggest that EF24 can intracellularly rescue S-nitroso
modification of PDI as seen under elevated levels of nitrosative stress and prevent Lewy-neurite
formation in my experimental model system and thus, EF24 acts as a potent prophylactic against
rotenone induced apoptotic cell death.
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Chapter 5:
The Impact of Nitrosative-Stress-Linked PDI Damage on Estrogenic Status of Cells

5.1 Introduction
The role of PDI on protein folding is been well-studied in the previous chapters. Recent
studies have demonstrated PDI plays a very crucial role in breast cancel study by maintaining the
homeostasis of estrogen receptors (15, 17). In this chapter I have dicussed the impact of
rotenone-induced chemical modification of PDI on estrogenic status; prevention against the
alteration of estrogenic status by small molecule intervention. Breast cancer is the second leading
cause of cancer-related deaths in women worldwide and approximately almost 1.5 million
women are diagnosed with breast cancer annually (1). It is well-known that estrogen plays
important physiological roles not only in women but also in men and that the biological effects
of estrogen are mediated by estrogen receptors. Estrogen receptor super-family consists of two
homologous nuclear receptors, estrogen receptor alpha (Erα) and estrogen receptor beta (Erβ)
(2). Erα and Erβ exhibit different transcriptional activities and functions in breast cancer. Erα is
expressed in approximately 70% of human breast cancer patients (3).The ratio between Erα and
Erβ is important to maintain cellular homeotsasis. Evidence has demonstrated overexpression of
Erα relative to Erβ in breast cancer cells compared to normal tissues suggesting that disruption of
Erβ/Erα expression may lead to breast carcinogenesis (4). The abundance of Erβ in the male
urogenital tract has also refocused attention on the role of estrogen in males (5). Similar to Er, Gprotein coupled ER1 (GPER; previously known as GPR30) can be activated by a wide variety of
Er agonists like 17β-estradiol as well by partial antagonists such as tamoxifen. The role of GPER
in breast cancer is still not clear (6). Among the plethora of biological effects, angiogenesis, cell
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proliferation and invasiveness are most common features exerted during breast cancer, which are
related to direct interaction of estrogen with an intracellular receptor that activates the expression
of genes encoding proteins (7). The hormonal actions of estrogen are as important to maintain
the normal female physiology including the development of target organs as it contributes to
tumor formation in certain target organs. In addition, estrogen receptors have also been reported
to play crucial role in bone maintenance as well as in mediating E2-induced rapid signal
transduction (2-5).
PDI (Fig.3.1A), a chief ER resident oxidoreductase molecular chaperone, plays a central role
in oxidative protein folding catalysis (8-11). In addition, it was suggested that PDI can interact
directly with ERα (12-14) with its Er-interacting property very similar to Hsp90 and Hsp70, two
well-known chaperone proteins that can alter Er functions (15, 16). PDI, with its possible impact
on Erα, acts as a modulator of estrogen’s hormonal activity in different target cells. The
intracellular PDI-bound estrogens can be released from PDI to initiate the Er-mediated
transcriptional activity as well as mitogenic actions (17). Studies suggest that PDI plays a critical
role in estrogen responsiveness by functioning as a molecular chaperone and PDI alone is
capable of interacting with Erα and influencing its activity (18). I observed that, PDI can alter
Erβ to Erα ratio significantly by altering the levels of two proteins in opposite directions, downregulation of Erα and up-regulation of Erβ. The human estrogen receptors are expressed in breast
cancer MCF-7 cells and play a major role in tumorigenic processes (19).
In this study, I chose to evaluate PDI’s ability to maintain Erα and Erβ levels in MCF-7 cell
under control and nitrosative stress conditions. Initially, I gathered the evidence to show that PDI
is S-nitrosylated (SNO-P), and NO-induced chemical modification of PDI abolishes its ability to
maintain Erβ/Erα ratio by altering the levels of Erβ and Erα. Using a battery of biochemical and
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molecular techniques, I have demonstrated PDI colocalization with Erα in MCF-7 nuclei under
normal and nitrosative stress condition, using a variety of molecular and biochemical
approaches. The selected polyphenol, EF24 (Fig. 3.1B) was then introduced to determine
whether they can rescue PDI-dependant Erα and Erβ function and furthermore, prevent the
change in receptor proteins levels. My results indicate that EF24 promotes the homeostasis of
estrogen in target cell. The implications for prevention of nitrosative stress effect induced
endogenous estrogens related different disorders are discussed.

5.2 Materials and Methods
Reagents and cell line.
Reagents were purchased as follows: Mouse monoclonal PDI (Abcam, Cambridge, MA,
USA), rabbit polyclonal Erα (Santa cruz, Santa cruz, CA, USA), Erβ (Invitrogen, Carlsbad, CA,
USA) and GAPDH (Glyceraldehyde 3-phosphate dehydrogenase, Cell Signalling, Danvers, MA,
USA), horseradish peroxidase (HRP)-conjugated goat anti-mouse and/or goat anti-rabbit IgG
(KPL Biomedical) and MCF-7 (Obtained from ATCC, Manassas, VA).
Cell Culture.
Human breast adenocarcinoma cells (MCF-7) were cultured in RPMI-1640 media (Roswell
Park Memorial Institute-1640, pH 7.2, Hyclone Laboratory) supplemented with 10% fetal bovine
serum (Atlanta Biologicals) and 100 U/ml penicillin-streptomycin (Sigma). Cells were incubated
in 5% CO2 and 78% relative humidity at 37 °C. MCF-7 cells (1×106 cells/well) were seeded
onto 6-well plates in RPMI-1640 at 37 °C in 5% CO2 incubator. After 12 hrs, cells were treated
with different concentrations of EF24 and various concentrations of rotenone.
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Rotenone and EF24 treatment.
Cells were treated with 1µM EF24 for 3 hrs and followed by treatment with 400 nM of
rotenone for 2 hrs. Total cellular protein extracts Ire prepared by washing the cells with cold
Tris-buffered saline, collected by centrifugation (3003g, 5 min at 48ºC), and extracted by
sonicating in buffer containing 10 mM Tris–HCl (pH 7.4), 10 mM EDTA, 2% (w/v) SDS and
protease inhibitors (Sigma). Total protein concentrations were measured using a bicinchonic acid
kit (Pierce) and subjected to immunoblot analyses.
Immunoblot analyses.
Blots were incubated in blocking buffer (5%, w/v, dried skimmed milk in Tris-buffered
saline, pH 7.4, and 0.1% TIen 20) then developed using anti-PDI monoclonal antibody (1:500
abcam) or anti-Erα antibody(1:100 dilution) or anti-Er-β antibody (1:100 dilution) or antiGAPDH (Glyceraldehyde 3-phosphate dehydrogenase, 1:1000 dilution) diluted in blocking
buffer and applied for 1 h at RT and incubated with horse radish peroxidase (HRP)-conjugated
goat anti-mouse or anti-rabbit (KPL Biomedical) in 1% BSA in TBST for 30 min.
Chemiluminescence (ECL-plus or SuperSignal Ist Pico Chemiluminescent Substrate) was used
according to the manufacturer’s (Amersham or Pierce Biotechnology Inc.) instructions for
detection of protein. Antibody binding was revealed using peroxidase-conjugated secondary
antibodies and enhanced Chemiluminescence (ECL-plus

or

SuperSignal

west

Pico

Chemiluminescent Substrate) according to facturer’s (Amersham or Pierce Biotechnology Inc.)
protocols.
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Confocal microscopy and immunocytochemistry.
For confocal microscopy, cells were pre-treated with 1µM EF24 for 3 hrs, followed by 400
nm rotenone for 2 hrs as described above. For controls, cells were treated with DMSO, EF24,
and rotenone, as mentioned in the experimental samples. Next, cells were fixed with methanol
(100%) and incubated at –20 °C for 5 min before blocking with 5% normal goat serum (NGS).
Then, cells were incubated overnight at 4ºC with respective primary antibodies i.e., anti-PDI
(monoclonal, 1:500), anti- Er-α or anti-Er-β (1:100) in 1% NGS. The slides were washed and
reacted with Fluorescein isothiocyanate (FITC) conjugated goat anti-rabbit IgG (for Erα and or
Erβ), and Rhodamine conjugated goat anti-mouse IgG (for PDI) in 1:100 dilution. The cells were
counter-stained with 10 mg/mL 4′-6-Diamidino-2-phenylindole (DAPI), mounted with DAKO
medium (DAKO Corporation, CA) and visualized by confocal microscopy (Zeiss LSM 700
confocal).

5.3 Results
Impact of reactive oxygen species on PDI and attenuation by polyphenol EF24.
Immunoblot assay was done with PDI antibody to show the effect of rotenone and EF24 on
expression level of PDI in MCF-7 cell. Result shows that the levels of expression of PDI as a
function of increasing concentrations of rotenone (Fig. 5.1A). A dose-dependent decrease in
oxidoreductase expression is observed as rotenone levels increase as evidenced by immunoblot
analysis Lane 3 and 4). This attenuation in PDI expression may couple with the modification of
the oxidoreductase active site and loss of oxidoreductase activity. Remarkably, pretreatment of
the cells with EF24 prior to rotenone infusion shows that the polyphenol is able to rescue PDI
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expression (Lane 5 and 6) and mitigate loss of oxidoreductase functionality. Densitometric
analysis (Fig. 5.1B) of this immunoblot assay using Glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) as the intrinsic control confirmed that intervention by EF24 restores PDI levels to
those observed in the absence of rotenone-dependent ROS infusion.

Figure 5.1. Effect of EF24 and rotenone on PDI expression in MCF-7 cells (A) MCF-7 cells
were treated with rotenone and EF24 at different concentrations (range) and cell lysates were
analyzed by immunoblot using PDI antibody (monoclonal). Lane 1, untreated cell lysates. Lane
2, cells were treated with 600 nm EF24 alone for 5 hrs. Lane 3 and 4, cells were treated with 400
nm and 200 nm rotenone for 2 hrs. Lane 5 and 6, cells were stressed with 400 nm and 200 nm
rotenone for 2 hrs after pre-incubation with 600 nm and 300 nm EF24 for 3 hrs. GAPDH was
used as a loading control. Results are representatives of triplicates (B) Densitometric analysis of
PDI protein level in MCF-7 cells
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S-nitrosylation of PDI in MCF-7 cells is associated with down-regulation of Erα but upregulation of Erβ.
Fig 5.2 and 5.3 are results from immunoblot assays performed with Erα and Erβ antibodies to
show the effect of rotenone and EF24 on expression level of Erα and Erβ in MCF-7 cells;
immunoblotting and densitometric analysis of these immunoblot assays using GAPDH as the
control confirmed that PDI-dependent Erα levels were significantly decreased as a function of
rotenone concentration (lane 1 vs. 3 and 4 in fig. 5.2). In contrast, and in agreement with
previous studies, Erβ levels rose as a function of rotenone concentration and PDI compromise
(Lane 1 vs. 3 and 4 in Fig. 5.3).
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Figure 5.2. Effect of EF24 and rotenone on ERα expression in MCF-7 cells (A) MCF-7 cells
were treated with Rotenone and EF 24 at different concentrations and cell lysates were analyzed
by Western blot with Erα antibody. Lane 1, untreated cell lysates. Lane 2, cells were treated with
600 nm EF24 alone for 5 hrs. Lane 3 and 4, cells were treated with 200 nm and 400 nm rotenone
for 2 hrs. Lane 5 and 6, cells were stressed with 200 nm and 400 nm rotenone for 2 hrs after preincubation with 300 nm and 600nm EF24 for 3 hrs. GAPDH was used as a loading control.
Results are representatives of triplicates (B) Densitometric analysis of Erα protein level in MCF7 cells.

The PDI-dependent Erβ/Erα ratio increased to a significant level in the presence of rotenone.
My data demostrate the impact of EF24 incubation on the cell line prior to rotenone addition
(Fig. 5.2 and 5.3). In the presence of EF24 and rotenone, both Erα and Erβ levels were returned
to those in the absence of rotenone. The observed Erβ/Erα ratio was also found to be in
agreement with the results obtained in the absence of rotenone. Those observed during
homeostasis (lane 1 and 2 in Fig. 5.2 and 5.3) measurement of Er receptor proteins. This
observation reveals that in MCF-7 cells upon S-nitrosylation of PDI, the Erβ to Erα ratio would
have significantly increased.
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Figure 5.3. Effect of EF24 and rotenone on Erβ expression in MCF-7 cells (A) MCF-7 cells
were treated with Rotenone and EF24 at different concentrations and cell lysates were analyzed
by Western blot with Erβ antibody. Lane 1, untreated cell lysates. Lane 2, cells were treated with
600 nm EF24 alone for 5 hrs. Lane 3 and 4, cells were treated with 200 nm and 400 nm rotenone
for 2 hrs. Lane 5 and 6, cells were stressed with 200 nm and 400 nm rotenone for 2 hrs after preincubation with 300 nm and 600 nm EF24 for 3 hrs. GAPDH was used as a loading control.
Results are representatives of triplicates (B) Densitometric analysis of Erβ protein level in MCF7 cells.

EF24 helps to maintain Erβ/Erα ratio in MCF-7 cells.
MCF-7 cells pretreated with EF24 for 3 hrs prior to the addition of rotenone and subsequent
2 hrs incubation showed no significant changes of Erα and Erβ protein levels in MCF-7 cells.
EF24 can scavenge the nitrosative stress of rotenone on PDI and maintain ERα protein level by
preventing the down-regulation of Erα (lane 1 vs. 5 and 6 in Fig. 5.2A) and simultaneously
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maintains Erβ protein level in cells by preventing up-regulation of Erβ (lane 1 vs. 5 and 6 in Fig.
5.3A). Densitometric analysis of these immunoblot assays using GAPDH as the control showed
down-regulation of Erα and up-regulation of Erβ upon rotenone treatment but this imapct (of
rotenone) is rescued by EF24 (Fig. 5.2B and 5.3B).
Effect of rotenone on Erα expression level in MCF-7 cells and prophylactic intervention of
EF24.
Confocal microscopic and immunocytochemistry analysis performed to analyze the effect of
rotenone and EF24 on MCF-7 cells (Fig. 5.4) show Erα expression level decreases significantly
when cells Ire stressed with 400 nm rotenone for 2 hrs (Fig. 5.4F). In contrast, the ERα
expression level in cells (Fig. 5.4G), pretreated with 1µM EF24 for 3 hrs and followed by 400
nm rotenone insult for 2 hrs, closely resembles to Erα expression level in untreated cell. As a
control for non-specific effects, untreated (Fig. 5.4D) and 1µM EF24 treated (Fig. 5.4E) cells
were included. These results show that EF24 has prophylactic effect against nitrosative stress and
plays vital role in maintaining Erα expression level in MCF-7 cells.
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Figure 5.4. Expression and localization of PDI and Erα in MCF-7 cells, and effect of EF24 and
rotenone on Erα distribution in MCF-7 cells. Confocal fluorescence images of MCF-7 cells
reveal the distribution of PDI and Erα in cells. (A) Cells stained with DAPI showing nucleus in
blue color (B) Cells stained with rhodamine showing PDI in red color, (C) Cells stained with
FITC showing Erα in green color, (D) Expression of Erα in untreated cells, (E) Erα expression
level when cells were treated with 1µM EF24 alone, (F) Erα expression level when cells were
exposed to 400 nm rotenone for 2 h, and (G) Cells pretreated with 600 nm EF24 for 3 hrs
followed by 400 nm rotenone treatment for 2 hrs. All the cover-glasses were counterstained with
DAPI, to delimitate the nucleolus (blue color).
Effect of rotenone on Erα and PDI colocalization in MCF-7 cells and prophylactic intervention
of EF24.
As it has been earlier determined that PDI binds with Erα and helps to maintain Erα level in
MCF-7 cells, I was interested to investigate whether there is colocalization of PDI and Erα under
both homeostasis and stress conditions. Confocal images show Erα and PDI colocalization
diminizes significantly when cells were stressed with 400 nm rotenone for 2 hrs (Fig. 5.5C).
Again, the colocalization levels in cells (Fig. 5.5D), pretreated with 600 nm EF24 for 3 hrs and
followed by 400 nm rotenone insult for 2 hrs, is compared to controls. As a control for nonspecific effects, untreated (Fig. 5.5A) and 1µM EF24 treated (Fig. 5.5B) cells were included.
These results show that EF24 has prophylactic effect against nitrosative stress and plays vital
role in maintaining homeostasis of Erα in MCF-7 cells.
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Figure 5.5. Confocal fluorescence images of MCF-7 cells reveal the colocalization (yellow zone
indicated by White arrow) of PDI and Erα in cells. MCF-7 cells were untreated or stressed with
rotenone and processed for immunofluorescence as detailed in the Materials and methods
section. (A) Colocalization in untreated cell, (B) Colocalization after cells were treated with 1
µM EF24 treatment, (C) Colocalization in cells after 400 nm rotenone insult for 2 h, and (D)
Colocalization was compared to control when cells were pretreated with 600 nm EF24 for 3 hrs
followed by 400 nm rotenone treatment for 2 hrs. All the cover-glasses were counterstained with
DAPI, rhodamine, and FITC to delimitate the nucleolus (in blue color), PDI (in red color), and
Erα (in green color) respectively.

5.4 Discussion
PDI is a well-known protein folding catalyst that possesses high-capacity intracellular
estrogen-binding properties and can modulate the estrogen receptor proteins levels (15). The
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estrogen receptor protein-interacting ability of PDI may offer an explanation for the intriguing
property of estrogen status maintenance in target tissues (such as breast cancer tissue). Inherent
interaction of PDI with estrogen receptor protein is an important modulator of estrogen’s
hormonal activity. My results provide definitive evidence demonstrating that PDI can
significantly alter the ratio of Erβ to Erα by altering the levels of these two proteins in opposite
directions under nitrosative stress condition. This unique function of PDI offers new mechanistic
insights into the modulation of estrogenic status in target cells. This is important because
nitrosative stress represents a threat to estrogen receptor protein levels through PDI and
alterations in these levels have been shown to be associated with onset of defective reproductive
organs development (16).
My study has established that EF24, is able to protect PDI function under conditions of
nitrosative stress by scavenging free radical (NO*) and forming stable adducts which result in
homeostasis of Erβ/Erα ratio. This finding offers new mechanistic insights into intervention of
estrogenic status in target cells. Importantly, my data demonstrate that EF24 can serve as lead
prophylactics in the search for small molecules that can prevent the nitrosative stress-related
damage in estrogen status which is pivotal in reproductive organs development. My elucidation
of an NO-mediated dysfunction of PDI provides a possible mechanistic link between free radical
production, and inactive PDI in breast cancer cell lines via abnormal level of estrogenic status.
My results also provide a route for prophylacxis (through EF24). The elucidation of this SNOPDI-mediated pathway that contributes to neuronal disorder, and the prophylactic mechanism of
a polyphenol might permit the development of new therapeutic approaches for cancer and other
disorders associated with excessive NOS production related PDI dysfunction.
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Chapter 6:
Summary and Concluding Remarks

6.1 Summary and concluding remarks
Protein traffic in the ER comprises incoming nascent chains that need to fold; outgoing
bioactive polymers constitute the secretory pathway; and, terminally misfolded debris constitutes
the retrotranslocatory pathway (25). Efficient catalytic function of PDI is pivotal to facilitating
the majority of incoming traffic along the secretory pathway. Compromised PDI activity can
compromise fold maturation, reduce secretory traffic and increase retrotranslocatory flux; in
turn, retrotranslocatory debris destined for the proteosome can overwhelm the cytosolic
housekeeping machinery and lead to the onset of neuropathies (Scheme 4.1) (25, 26).
Even under conditions of homeostasis, the evolution of PDI as an oxidoreductase can reduce
fold maturation yields in the physical folding step of oxidative folding resulting in compromised
processing of secretory traffic. Results from this study imply that the self-limited catalytic
potential of PDI may detract a portion of the incoming flux from exiting the ER through the
secretory pathway (Chapter 2). Such a subset of the incoming flux would then constitute the
retrotranslocatory pathway and impose a burden on the cytosolic housekeeping machinery. The
retrotranslocatory flux from the ER to the cytosol can thus set-up conditions where aggregationprone cytosolic proteins such as synphilin-1, synuclein, A escape surveillance by housekeeping
leading to the onset of neuropathies such as Alzheimer’s and Parkinson’s diseases (4, 25, 26).
Nitrosative and oxidative stress, associated with the generation of excessive reactive oxygen
or nitrogen species, are thought to contribute to neurodegenerative disorders. Many such diseases
are characterized by conformational changes in proteins that result in their misfolding and
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aggregation (25). Accumulating evidence implies that at least two pathways affect protein
folding: the ubiquitin-proteasome system (UPS) and molecular chaperones (26). Normal protein
degradation by the UPS can prevent accumulation of aberrantly folded proteins. Molecular
chaperones, PDI, glucose-regulated protein 78, and heat shock proteins, can provide
neuroprotection from aberrant proteins by facilitating proper folding and thus preventing their
aggregation. My recent studies have linked oxidative and nitrosative stress to protein misfolding
and neuronal cell death.
It was suggested that PDI can interact directly with estrogen receptor (Erα) [18-20] with its
estrogen-interacting property very similar to Hsp90 and Hsp70, two well-known chaperone
proteins that can alter ER functions [21-22]. PDI, with its possible Erα chaperoning activity, acts
as a modulator of estrogen’s hormonal activity in different target cells (23). The intracellular
PDI-bound estrogens can be released from PDI to instigate the Er-mediated transcriptional
activity as well as mitogenic actions [23]. My study demonstrated that during nitrosative stress,
excess generation of NO* species leads to compromise of PDI’s activity; in turn, this causes a
diminution of colocalization with estrogen receptor (Erα). Such a scenario can alter the
homeostasis of estrogenic status and leads to cancer.
A goal of this dissertation was to determine whether polyphenolic phytochemical can protect
PDI from free radical stress. My combined data reveal that though polyphenloic intervention,
PDI can be rescued from chemical modification under ROS-stress. As a result, its catalytic
activity can be restored. Restored catalytic activity of PDI is important for maintaing levels of
secretory traffic under ROS stress; neuroprotection of select cell types through mitigation in the
accumulation of neurodegenerative biomarkers; and in the estrogenic status of other cell types.
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6.2 Future directions and discussion
After intensive studies with the prophylactic properties of EF24 against free-radical stress, I
was interested to further my research to investigate other chemical compounds which can serve
as lead compounds against neuropathy. Therefore, future direction of this dissertation was
designed to investigate the prophylactic effect of those compounds against free-radical stress
induced pathogenesis. It has been postulated that the pathogenesis of Parkinson’s disease (PD) is
associated with mitochondrial dysfunction (1). Rotenone, an inhibitor of mitochondrial complex
I, provides models of PD both in vivo and in vitro (2). During the search for lead compounds
against free radical stress, I investigated the neuroprotective effect of Na-D-β-hydroxybutyrate
(NaβHB), a ketone body, against rotenone toxicity by using SH-SY5Y dopaminergic
neuroblastoma cells. Pretreatment of cells with NaβHB provided significant protection to
SHSY5Y cells. NaβHB attenuated the rotenone-induced activation of caspase-9 and caspase-3.
These data demonstrated that NaβHB had a neuroprotective effect that supported the
mitochondrial respiration system by reversing the inhibition of complex I. My preliminary
results provide an indication that ketone bodies, the alternative energy source in the mammalian
brain, appear to have therapeutic potential in PD and opens up a broad area of future research
where therapeutic effect of these ketone bodies against neurodegenerative diseases would be a
valuable investigation.
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Figure 6.1. Cytotoxicity assay in SH-SY5Y cells. (A) Shows the cytotoxic effect of different
concentrations of sodium beta hydroxy butyrate (NaβHB) treatment (24 hrs) on the viability of
SH-SY5Y cells. (B) Shows the protective effect of NaβHB (100µM) on rotenone induced
cytotoxicity of SH-SY5Y cells. Cells were stained with hoechst (live cells) and propidium
iodide (PI; dead cells) and further the viability is detected using differential nuclear staining
assay.
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Figure 6.2. Representative images of untreated SH-SY5Y cells by using differential nuclear
staining assay. The three images correspond to the same portion of the 3X3 montage, captured
with 20X objective utilizing BD Pathway Bioimager system and AttoVison software. (A)
Hoechst emission signal from stained cells indicates the total number of nuclei (cells) present in
the image, shown in blue. (B) Propidium iodide emission signal from labeled cell nucleus
indicates the number of death cell in the image, shown in red. (C) Merged Hoechst and PI image,
from signals of the two fluorescence channel; the magenta color is an outcome of co-localization
of red and blue colors, indicating the number of dead cells in the image.

Figure 6.3.Detection of cellular apoptosis/ necrosis in SH-SY5Y cells induced by NaβHB (100
µM) and rotenone (RT) treatment. Cells were treated with NaβHB for 6 hrs and 24 hrs duration
and with RT for 18hrs followed by staining with annexin-V FITC (apoptotic marker) and PI
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(necrotic marker). Afterwards the percentage of apoptotic and necrotic cell population was
quantitated using a flow cytometer.

Figure 6.4. Histogram of flow cytometric analyses on SH-SY5Y cells. (A), (B), (C) show the
untreated control, vehicle control (Dimethyl sulfoxide; DMSO) and positive control (150 mM
H2O2) respectively. (D) and (E) show the effect of sodium beta hydroxy butyrate (NaβHB ; 100
µM) and rotenone (300 nM) respectively. (F) shows the protective effect of NaβHB on the
rotenone-induced cytotoxicity and apoptotic cell death.
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Figure 6.5. Protective effect of NaβHB (100 µM) against rotenone (300 nM) induced poly(ADPribose) polymerase (PARP) cleavage (a marker of apoptosis progression) in SH-SY5Y cells.
PARP cleavage was analyzed via Isternblot analysis (n=1). Whole cell protein extracts Ire
separated using polyacrylamide gel electrophoresis and transferred to a polyvinylidene fluoride
(PVDF) membrane, folloId by immunoblot analysis utilizing antibodies anti-PARP.
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Figure 6.6. Confocal fluorescence images of SHSY5Y cells reveal the presence of
intracytoplasmatic aggregates in cells transfected with EGFP or EGFP-tagged synphilin-1
plasmid. Transfected SHSY5Y cells were untreated or stressed with rotenone and processed for
immunofluorescence as detailed in the Materials and methods section. (A) cells transfected with
pEGFP-C2 without synphilin-1 insert; (B) cells untreated; (C) Cells treated with DMSO 2.5 v/v;
(D) Cells exposed to 300 nM rotenone for 12 h alone; (E) cells pretreated with 500 µM NaβHB
for 3 h were exposed to 300 nM rotenone for 12 h. All the cells were counterstained with DAPI
to delimitate the nucleolus (blue color). White arrows indicate the presence of aggregates
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corresponding to the recombinant fusion protein and yellow arrow represents GFP expression.
Corresponding part of each figure represents Differential Interference Contrast (DIC) picture.
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